1	Identification	identification	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	collagen	collagen	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	induced	induce	VBN	_	7	NMOD
6	arthritis	arthritis	NN	_	7	NMOD
7	loci	locus	NNS	_	2	PMOD
8	in	in	IN	_	1	LOC
9	aged	aged	JJ	_	12	NMOD
10	multiparous	multiparous	JJ	_	12	NMOD
11	female	female	JJ	_	12	NMOD
12	mice	mouse	NNS	_	8	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Collagen	collagen	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	induced	induce	VBN	_	4	NMOD
4	arthritis	arthritis	NN	_	7	SBJ
5	in	in	IN	_	4	LOC
6	mice	mouse	NNS	_	5	PMOD
7	is	be	VBZ	_	0	ROOT
8	one	one	CD	_	7	PRD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	16	NMOD
11	most	most	RBS	_	12	AMOD
12	commonly	commonly	RB	_	13	AMOD
13	used	use	VBN	_	16	NMOD
14	autoimmune	autoimmune	JJ	_	16	NMOD
15	experimental	experimental	JJ	_	16	NMOD
16	models	model	NNS	_	9	PMOD
17	,	,	,	_	8	P
18	with	with	IN	_	8	NMOD
19	many	many	JJ	_	20	NMOD
20	similarities	similarity	NNS	_	18	PMOD
21	to	to	IN	_	20	NMOD
22	rheumatoid	rheumatoid	JJ	_	23	NMOD
23	arthritis	arthritis	NN	_	21	PMOD
24	.	.	.	_	7	P

1	Since	since	IN	_	12	PRP
2	collagen	collagen	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	induced	induce	VBN	_	5	NMOD
5	arthritis	arthritis	NN	_	6	SBJ
6	is	be	VBZ	_	1	SUB
7	a	a	DT	_	10	NMOD
8	complex	complex	JJ	_	10	NMOD
9	polygenic	polygenic	JJ	_	10	NMOD
10	disease	disease	NN	_	6	PRD
11	there	there	EX	_	12	SBJ
12	is	be	VBZ	_	0	ROOT
13	a	a	DT	_	14	NMOD
14	need	need	NN	_	12	PRD
15	for	for	IN	_	14	NMOD
16	identification	identification	NN	_	15	PMOD
17	of	of	IN	_	16	NMOD
18	several	several	JJ	_	23	NMOD
19	major	major	JJ	_	23	NMOD
20	disease	disease	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	controlling	control	VBG	_	23	NMOD
23	genes	gene	NNS	_	17	PMOD
24	.	.	.	_	12	P

1	Because	because	IN	_	10	PRP
2	rheumatoid	rheumatoid	JJ	_	3	NMOD
3	arthritis	arthritis	NN	_	5	SBJ
4	particularly	particularly	RB	_	5	ADV
5	affects	affect	VBZ	_	1	SUB
6	aged	aged	JJ	_	7	NMOD
7	women	woman	NNS	_	5	OBJ
8	,	,	,	_	10	P
9	we	we	PRP	_	10	SBJ
10	have	have	VBP	_	0	ROOT
11	in	in	IN	_	10	ADV
12	the	the	DT	_	14	NMOD
13	present	present	JJ	_	14	NMOD
14	study	study	NN	_	11	PMOD
15	identified	identify	VBN	_	10	VC
16	new	new	JJ	_	18	NMOD
17	genetic	genetic	JJ	_	18	NMOD
18	regions	region	NNS	_	15	OBJ
19	critical	critical	JJ	_	18	NMOD
20	for	for	IN	_	19	AMOD
21	collagen	collagen	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	induced	induce	VBN	_	24	NMOD
24	arthritis	arthritis	NN	_	20	PMOD
25	by	by	IN	_	15	MNR
26	studying	study	VBG	_	25	PMOD
27	aged	aged	JJ	_	29	NMOD
28	female	female	JJ	_	29	NMOD
29	mice	mouse	NNS	_	26	OBJ
30	of	of	IN	_	29	NMOD
31	a	a	DT	_	32	NMOD
32	cross	cross	NN	_	30	PMOD
33	between	between	IN	_	32	NMOD
34	NFR	nfr	NN	_	36	NMOD
35	/	/	HYPH	_	34	P
36	N	n	NN	_	33	PMOD
37	and	and	CC	_	36	COORD
38	B10.Q	b0.q	NN	_	37	CONJ
39	(	(	-LRB-	_	43	P
40	H	h	NN	_	42	NMOD
41	-	-	HYPH	_	40	P
42	2q	0q	NN	_	43	NMOD
43	haplotype	haplotype	NN	_	32	PRN
44	)	)	-RRB-	_	43	P
45	.	.	.	_	10	P

1	The	the	DT	_	2	NMOD
2	mice	mouse	NNS	_	7	SBJ
3	in	in	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	present	present	JJ	_	6	NMOD
6	study	study	NN	_	3	PMOD
7	had	have	VBD	_	0	ROOT
8	different	different	JJ	_	10	NMOD
9	reproductive	reproductive	JJ	_	10	NMOD
10	histories	history	NNS	_	7	OBJ
11	,	,	,	_	10	P
12	which	which	WDT	_	13	SBJ
13	did	do	VBD	_	10	NMOD
14	not	not	RB	_	13	ADV
15	significantly	significantly	RB	_	13	ADV
16	affect	affect	VB	_	13	VC
17	the	the	DT	_	18	NMOD
18	onset	onset	NN	_	16	OBJ
19	,	,	,	_	18	P
20	incidence	incidence	NN	_	18	CONJ
21	or	or	CC	_	20	COORD
22	severity	severity	NN	_	21	CONJ
23	of	of	IN	_	18	NMOD
24	the	the	DT	_	25	NMOD
25	disease	disease	NN	_	23	PMOD
26	.	.	.	_	7	P

1	A	a	DT	_	2	NMOD
2	total	total	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	200	0	CD	_	6	NMOD
5	female	female	JJ	_	6	NMOD
6	mice	mouse	NNS	_	3	PMOD
7	were	be	VBD	_	0	ROOT
8	used	use	VBN	_	7	VC
9	in	in	IN	_	8	ADV
10	a	a	DT	_	15	NMOD
11	total	total	JJ	_	15	NMOD
12	genome	genome	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	wide	wide	JJ	_	15	NMOD
15	screening	screening	NN	_	9	PMOD
16	with	with	IN	_	15	NMOD
17	125	0	CD	_	19	NMOD
18	microsatellite	microsatellite	NN	_	19	NMOD
19	markers	marker	NNS	_	16	PMOD
20	.	.	.	_	7	P

1	We	we	PRP	_	2	SBJ
2	found	find	VBD	_	0	ROOT
3	one	one	CD	_	8	NMOD
4	new	new	JJ	_	8	NMOD
5	significant	significant	JJ	_	8	NMOD
6	quantitative	quantitative	JJ	_	7	NMOD
7	trait	trait	NN	_	8	NMOD
8	locus	locus	NN	_	2	OBJ
9	affecting	affect	VBG	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	arthritis	arthritis	NN	_	12	NMOD
12	incidence	incidence	NN	_	9	OBJ
13	,	,	,	_	12	P
14	severity	severity	NN	_	12	CONJ
15	and	and	CC	_	14	COORD
16	day	day	NN	_	15	CONJ
17	of	of	IN	_	16	NMOD
18	onset	onset	NN	_	17	PMOD
19	on	on	IN	_	2	LOC
20	chromosome	chromosome	NN	_	19	PMOD
21	11	0	CD	_	20	NMOD
22	(	(	-LRB-	_	23	P
23	denoted	denote	VBN	_	20	PRN
24	Cia40	cia0	NN	_	23	OPRD
25	)	)	-RRB-	_	23	P
26	,	,	,	_	20	P
27	which	which	WDT	_	28	SBJ
28	colocalizes	colocalizes	VBZ	_	20	NMOD
29	with	with	IN	_	28	ADV
30	a	a	DT	_	34	NMOD
31	locus	locus	NN	_	32	AMOD
32	controlling	control	VBG	_	34	NMOD
33	pregnancy	pregnancy	NN	_	34	NMOD
34	failure	failure	NN	_	29	PMOD
35	.	.	.	_	2	P

1	Furthermore	furthermore	RB	_	20	ADV
2	,	,	,	_	20	P
3	a	a	DT	_	6	NMOD
4	quantitative	quantitative	JJ	_	5	NMOD
5	trait	trait	NN	_	6	NMOD
6	locus	locus	NN	_	20	SBJ
7	of	of	IN	_	6	NMOD
8	suggestive	suggestive	JJ	_	9	NMOD
9	significance	significance	NN	_	7	PMOD
10	associated	associate	VBN	_	6	NMOD
11	with	with	IN	_	10	ADV
12	the	the	DT	_	13	NMOD
13	incidence	incidence	NN	_	11	PMOD
14	,	,	,	_	13	P
15	severity	severity	NN	_	13	CONJ
16	and	and	CC	_	15	COORD
17	day	day	NN	_	16	CONJ
18	of	of	IN	_	17	NMOD
19	onset	onset	NN	_	18	PMOD
20	was	be	VBD	_	0	ROOT
21	identified	identify	VBN	_	20	VC
22	on	on	IN	_	21	LOC
23	chromosome	chromosome	NN	_	22	PMOD
24	1	0	CD	_	23	NMOD
25	.	.	.	_	20	P

1	Finally	finally	RB	_	16	ADV
2	,	,	,	_	16	P
3	a	a	DT	_	8	NMOD
4	suggestively	suggestively	RB	_	5	AMOD
5	significant	significant	JJ	_	8	NMOD
6	quantitative	quantitative	JJ	_	7	NMOD
7	trait	trait	NN	_	8	NMOD
8	locus	locus	NN	_	16	SBJ
9	associated	associate	VBN	_	8	NMOD
10	with	with	IN	_	9	ADV
11	collagen	collagen	NN	_	15	NMOD
12	type	type	NN	_	15	NMOD
13	II	ii	CD	_	12	NMOD
14	antibody	antibody	NN	_	15	NMOD
15	titers	titer	NNS	_	10	PMOD
16	was	be	VBD	_	0	ROOT
17	identified	identify	VBN	_	16	VC
18	on	on	IN	_	17	LOC
19	chromosome	chromosome	NN	_	18	PMOD
20	13	0	CD	_	19	NMOD
21	.	.	.	_	16	P

1	This	this	DT	_	2	NMOD
2	study	study	NN	_	3	SBJ
3	indicates	indicate	VBZ	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	several	several	JJ	_	7	NMOD
6	gene	gene	NN	_	7	NMOD
7	loci	locus	NNS	_	8	SBJ
8	control	control	VBP	_	4	SUB
9	arthritis	arthritis	NN	_	8	OBJ
10	in	in	IN	_	8	LOC
11	aged	aged	JJ	_	13	NMOD
12	multiparous	multiparous	JJ	_	13	NMOD
13	females	female	NNS	_	10	PMOD
14	,	,	,	_	4	P
15	and	and	CC	_	4	COORD
16	that	that	IN	_	15	CONJ
17	at	at	RB	_	19	QMOD
18	least	least	RBS	_	17	AMOD
19	one	one	CD	_	23	SBJ
20	of	of	IN	_	19	NMOD
21	these	these	DT	_	22	NMOD
22	loci	locus	NNS	_	20	PMOD
23	coincides	coincide	VBZ	_	16	SUB
24	with	with	IN	_	23	ADV
25	pregnancy	pregnancy	NN	_	26	NMOD
26	failure	failure	NN	_	24	PMOD
27	.	.	.	_	3	P

1	Introduction	introduction	NN	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	similarities	similarity	NNS	_	21	SBJ
3	between	between	IN	_	2	NMOD
4	rheumatoid	rheumatoid	JJ	_	5	NMOD
5	arthritis	arthritis	NN	_	7	NMOD
6	(	(	-LRB-	_	7	P
7	RA	ra	NN	_	3	PMOD
8	)	)	-RRB-	_	7	P
9	in	in	IN	_	7	LOC
10	man	man	NN	_	9	PMOD
11	and	and	CC	_	7	COORD
12	collagen	collagen	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	induced	induce	VBN	_	15	NMOD
15	arthritis	arthritis	NN	_	17	NMOD
16	(	(	-LRB-	_	17	P
17	CIA	cia	NN	_	11	CONJ
18	)	)	-RRB-	_	17	P
19	in	in	IN	_	17	LOC
20	mice	mouse	NNS	_	19	PMOD
21	are	be	VBP	_	0	ROOT
22	well	well	RB	_	23	AMOD
23	established	establish	VBN	_	21	PRD
24	,	,	,	_	21	P
25	although	although	IN	_	21	ADV
26	differences	difference	NNS	_	31	SBJ
27	in	in	IN	_	26	NMOD
28	the	the	DT	_	30	NMOD
29	disease	disease	NN	_	30	NMOD
30	pattern	pattern	NN	_	27	PMOD
31	exist	exist	VBP	_	25	SUB
32	[	[	-LRB-	_	33	P
33	1	0	CD	_	21	PRN
34	-	-	SYM	_	35	P
35	3	0	CD	_	33	NMOD
36	]	]	-RRB-	_	33	P
37	.	.	.	_	21	P

1	Characteristic	characteristic	JJ	_	4	PRD
2	of	of	IN	_	1	AMOD
3	RA	ra	NN	_	2	PMOD
4	is	be	VBZ	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	fact	fact	NN	_	4	SBJ
7	that	that	IN	_	6	NMOD
8	women	woman	NNS	_	12	SBJ
9	of	of	IN	_	8	NMOD
10	reproductive	reproductive	JJ	_	11	NMOD
11	age	age	NN	_	9	PMOD
12	are	be	VBP	_	7	SUB
13	more	more	RBR	_	14	AMOD
14	susceptible	susceptible	JJ	_	12	PRD
15	to	to	IN	_	14	AMOD
16	the	the	DT	_	17	NMOD
17	disease	disease	NN	_	15	PMOD
18	than	than	IN	_	14	AMOD
19	men	man	NNS	_	18	PMOD
20	[	[	-LRB-	_	21	P
21	4	0	CD	_	4	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	4	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	also	also	RB	_	2	ADV
4	been	be	VBN	_	2	VC
5	reported	report	VBN	_	4	VC
6	that	that	IN	_	5	OBJ
7	75	0	CD	_	8	NMOD
8	%	%	NN	_	21	SBJ
9	of	of	IN	_	8	NMOD
10	female	female	JJ	_	11	NMOD
11	patients	patient	NNS	_	9	PMOD
12	(	(	-LRB-	_	17	P
13	23	0	CD	_	17	NMOD
14	out	out	IN	_	13	QMOD
15	of	of	IN	_	13	QMOD
16	31	0	CD	_	13	QMOD
17	females	female	NNS	_	11	PRN
18	)	)	-RRB-	_	17	P
19	with	with	IN	_	11	NMOD
20	RA	ra	NN	_	19	PMOD
21	exhibit	exhibit	VBP	_	6	SUB
22	clinical	clinical	JJ	_	23	NMOD
23	remission	remission	NN	_	21	OBJ
24	during	during	IN	_	21	TMP
25	the	the	DT	_	26	NMOD
26	course	course	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	pregnancy	pregnancy	NN	_	27	PMOD
29	[	[	-LRB-	_	30	P
30	5	0	CD	_	5	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	2	P

1	On	on	IN	_	7	ADV
2	the	the	DT	_	4	NMOD
3	other	other	JJ	_	4	NMOD
4	hand	hand	NN	_	1	PMOD
5	,	,	,	_	7	P
6	it	it	PRP	_	7	SBJ
7	has	have	VBZ	_	0	ROOT
8	been	be	VBN	_	7	VC
9	suggested	suggest	VBN	_	8	VC
10	that	that	IN	_	9	OBJ
11	the	the	DT	_	12	NMOD
12	onset	onset	NN	_	15	SBJ
13	of	of	IN	_	12	NMOD
14	RA	ra	NN	_	13	PMOD
15	is	be	VBZ	_	10	SUB
16	postponed	postpone	VBN	_	15	VC
17	by	by	IN	_	16	LGS
18	parity	parity	NN	_	17	PMOD
19	.	.	.	_	7	P

1	The	the	DT	_	2	NMOD
2	risk	risk	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	onset	onset	NN	_	3	PMOD
5	is	be	VBZ	_	0	ROOT
6	reduced	reduce	VBN	_	5	VC
7	during	during	IN	_	6	TMP
8	pregnancy	pregnancy	NN	_	7	PMOD
9	,	,	,	_	6	P
10	while	while	IN	_	6	ADV
11	in	in	IN	_	20	TMP
12	the	the	DT	_	14	NMOD
13	first	$#ORD#$	JJ	_	14	NMOD
14	year	year	NN	_	11	PMOD
15	postpartum	postpartum	RB	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	chance	chance	NN	_	20	SBJ
18	of	of	IN	_	17	NMOD
19	onset	onset	NN	_	18	PMOD
20	is	be	VBZ	_	10	SUB
21	increased	increase	VBN	_	20	VC
22	[	[	-LRB-	_	25	P
23	6	0	CD	_	25	NMOD
24	,	,	,	_	25	P
25	7	0	CD	_	6	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	14	SBJ
3	of	of	IN	_	2	NMOD
4	a	a	DT	_	6	NMOD
5	recent	recent	JJ	_	6	NMOD
6	study	study	NN	_	3	PMOD
7	of	of	IN	_	6	NMOD
8	RA	ra	NN	_	7	PMOD
9	in	in	IN	_	8	LOC
10	women	woman	NNS	_	9	PMOD
11	,	,	,	_	14	P
12	however	however	RB	_	14	ADV
13	,	,	,	_	14	P
14	indicate	indicate	VBP	_	0	ROOT
15	that	that	IN	_	14	OBJ
16	pregnancy	pregnancy	NN	_	17	NMOD
17	history	history	NN	_	18	SBJ
18	does	do	VBZ	_	15	SUB
19	not	not	RB	_	18	ADV
20	increase	increase	VB	_	18	VC
21	the	the	DT	_	22	NMOD
22	incidence	incidence	NN	_	20	OBJ
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	disease	disease	NN	_	23	PMOD
26	later	later	RB	_	20	TMP
27	in	in	IN	_	26	AMOD
28	life	life	NN	_	27	PMOD
29	[	[	-LRB-	_	30	P
30	8	0	CD	_	14	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	14	P

1	Adequate	adequate	JJ	_	3	NMOD
2	animal	animal	NN	_	3	NMOD
3	models	model	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	useful	useful	JJ	_	6	NMOD
6	tools	tool	NNS	_	4	PRD
7	for	for	IN	_	6	NMOD
8	the	the	DT	_	9	NMOD
9	identification	identification	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	genes	gene	NNS	_	10	PMOD
12	involved	involve	VBN	_	11	NMOD
13	in	in	IN	_	12	ADV
14	complex	complex	JJ	_	16	NMOD
15	human	human	JJ	_	16	NMOD
16	diseases	disease	NNS	_	13	PMOD
17	.	.	.	_	4	P

1	CIA	cia	NN	_	4	SBJ
2	in	in	IN	_	1	LOC
3	mice	mouse	NNS	_	2	PMOD
4	shares	share	VBZ	_	0	ROOT
5	both	both	CC	_	6	COORD
6	immunological	immunological	JJ	_	9	NMOD
7	and	and	CC	_	6	COORD
8	pathological	pathological	JJ	_	7	CONJ
9	characteristics	characteristic	NNS	_	4	OBJ
10	with	with	IN	_	4	ADV
11	human	human	JJ	_	12	NMOD
12	RA	ra	NN	_	10	PMOD
13	and	and	CC	_	4	COORD
14	is	be	VBZ	_	13	CONJ
15	one	one	CD	_	14	PRD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	20	NMOD
18	most	most	RBS	_	19	AMOD
19	used	use	VBN	_	20	NMOD
20	models	model	NNS	_	16	PMOD
21	for	for	IN	_	20	NMOD
22	the	the	DT	_	23	NMOD
23	identification	identification	NN	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	genes	gene	NNS	_	24	PMOD
26	and	and	CC	_	25	COORD
27	mechanisms	mechanism	NNS	_	26	CONJ
28	involved	involve	VBN	_	25	NMOD
29	in	in	IN	_	28	ADV
30	arthritis	arthritis	NN	_	29	PMOD
31	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	incidence	incidence	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	CIA	cia	NN	_	3	PMOD
5	is	be	VBZ	_	0	ROOT
6	sex	sex	NN	_	7	AMOD
7	dependent	dependent	JJ	_	5	PRD
8	,	,	,	_	5	P
9	like	like	IN	_	5	ADV
10	the	the	DT	_	11	NMOD
11	incidence	incidence	NN	_	9	PMOD
12	in	in	IN	_	11	NMOD
13	RA	ra	NN	_	12	PMOD
14	,	,	,	_	5	P
15	although	although	IN	_	5	ADV
16	different	different	JJ	_	17	NMOD
17	species	specie	NNS	_	24	SBJ
18	and	and	CC	_	17	COORD
19	different	different	JJ	_	20	NMOD
20	variants	variant	NNS	_	18	CONJ
21	of	of	IN	_	17	NMOD
22	the	the	DT	_	23	NMOD
23	disease	disease	NN	_	21	PMOD
24	could	could	MD	_	15	SUB
25	lead	lead	VB	_	24	VC
26	to	to	IN	_	25	ADV
27	both	both	CC	_	28	COORD
28	male	male	JJ	_	31	NMOD
29	and	and	CC	_	28	COORD
30	female	female	JJ	_	29	CONJ
31	predominance	predominance	NN	_	26	PMOD
32	.	.	.	_	5	P

1	Male	male	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	more	more	RBR	_	5	AMOD
5	often	often	RB	_	3	TMP
6	affected	affect	VBN	_	3	VC
7	than	than	IN	_	5	AMOD
8	females	female	NNS	_	7	PMOD
9	.	.	.	_	3	P

1	Gender	gender	NN	_	2	NMOD
2	differences	difference	NNS	_	6	SBJ
3	in	in	IN	_	2	NMOD
4	CIA	cia	NN	_	5	NMOD
5	susceptibility	susceptibility	NN	_	3	PMOD
6	are	be	VBP	_	0	ROOT
7	dependent	dependent	JJ	_	6	PRD
8	on	on	IN	_	7	AMOD
9	many	many	JJ	_	10	NMOD
10	factors	factor	NNS	_	8	PMOD
11	,	,	,	_	10	P
12	including	include	VBG	_	10	NMOD
13	genetic	genetic	JJ	_	18	NMOD
14	,	,	,	_	13	P
15	hormonal	hormonal	JJ	_	13	CONJ
16	and	and	CC	_	15	COORD
17	behavioral	behavioral	JJ	_	16	CONJ
18	influences	influence	NNS	_	12	PMOD
19	[	[	-LRB-	_	20	P
20	9	0	CD	_	6	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	6	P

1	However	however	RB	_	5	ADV
2	,	,	,	_	5	P
3	isolated	isolate	VBN	_	4	NMOD
4	factors	factor	NNS	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	remarkably	remarkably	RB	_	7	AMOD
7	consistent	consistent	JJ	_	5	PRD
8	between	between	IN	_	5	ADV
9	RA	ra	NN	_	8	PMOD
10	and	and	CC	_	9	COORD
11	the	the	DT	_	14	NMOD
12	different	different	JJ	_	14	NMOD
13	animal	animal	NN	_	14	NMOD
14	models	model	NNS	_	10	CONJ
15	[	[	-LRB-	_	18	P
16	3	0	CD	_	18	NMOD
17	,	,	,	_	18	P
18	9	0	CD	_	5	PRN
19	]	]	-RRB-	_	18	P
20	.	.	.	_	5	P

1	Pregnancy	pregnancy	NN	_	11	SBJ
2	in	in	IN	_	1	LOC
3	mice	mouse	NNS	_	2	PMOD
4	,	,	,	_	11	P
5	like	like	IN	_	11	ADV
6	pregnancy	pregnancy	NN	_	5	PMOD
7	in	in	IN	_	6	LOC
8	women	woman	NNS	_	7	PMOD
9	,	,	,	_	11	P
10	normally	normally	RB	_	11	ADV
11	causes	cause	VBZ	_	0	ROOT
12	remission	remission	NN	_	11	OBJ
13	of	of	IN	_	12	NMOD
14	arthritis	arthritis	NN	_	13	PMOD
15	[	[	-LRB-	_	18	P
16	5	0	CD	_	18	NMOD
17	,	,	,	_	18	P
18	10	0	CD	_	11	PRN
19	]	]	-RRB-	_	18	P
20	,	,	,	_	11	P
21	while	while	IN	_	11	ADV
22	exacerbation	exacerbation	NN	_	24	SBJ
23	often	often	RB	_	24	TMP
24	occurs	occur	VBZ	_	21	SUB
25	postpartum	postpartum	RB	_	24	TMP
26	[	[	-LRB-	_	31	P
27	7	0	CD	_	31	NMOD
28	,	,	,	_	31	P
29	10	0	CD	_	31	NMOD
30	,	,	,	_	31	P
31	11	0	CD	_	24	PRN
32	]	]	-RRB-	_	31	P
33	.	.	.	_	11	P

1	Pregnancy	pregnancy	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	induced	induce	VBN	_	4	NMOD
4	remission	remission	NN	_	9	SBJ
5	of	of	IN	_	4	NMOD
6	CIA	cia	NN	_	5	PMOD
7	in	in	IN	_	4	LOC
8	mice	mouse	NNS	_	7	PMOD
9	appears	appear	VBZ	_	0	ROOT
10	to	to	TO	_	9	OPRD
11	be	be	VB	_	10	IM
12	caused	cause	VBN	_	11	VC
13	by	by	IN	_	12	LGS
14	the	the	DT	_	15	NMOD
15	increase	increase	NN	_	13	PMOD
16	in	in	IN	_	15	NMOD
17	estrogen	estrogen	NN	_	18	NMOD
18	levels	level	NNS	_	16	PMOD
19	,	,	,	_	9	P
20	while	while	IN	_	9	ADV
21	the	the	DT	_	23	NMOD
22	postpartum	postpartum	NN	_	23	NMOD
23	exacerbation	exacerbation	NN	_	24	SBJ
24	can	can	MD	_	20	SUB
25	be	be	VB	_	24	VC
26	explained	explain	VBN	_	25	VC
27	by	by	IN	_	26	LGS
28	the	the	DT	_	30	NMOD
29	dramatic	dramatic	JJ	_	30	NMOD
30	drop	drop	NN	_	27	PMOD
31	in	in	IN	_	30	NMOD
32	estrogen	estrogen	NN	_	31	PMOD
33	[	[	-LRB-	_	34	P
34	10	0	CD	_	30	PRN
35	]	]	-RRB-	_	34	P
36	,	,	,	_	30	P
37	possibly	possibly	RB	_	38	AMOD
38	together	together	RB	_	30	NMOD
39	with	with	IN	_	38	AMOD
40	increased	increase	VBN	_	42	NMOD
41	prolactin	prolactin	NN	_	42	NMOD
42	levels	level	NNS	_	39	PMOD
43	[	[	-LRB-	_	44	P
44	11	0	CD	_	38	PRN
45	]	]	-RRB-	_	44	P
46	.	.	.	_	9	P

1	To	to	IN	_	10	ADV
2	what	what	WDT	_	3	NMOD
3	extent	extent	NN	_	1	PMOD
4	the	the	DT	_	6	NMOD
5	pregnancy	pregnancy	NN	_	6	NMOD
6	history	history	NN	_	10	SBJ
7	(	(	-LRB-	_	8	P
8	parity	parity	NN	_	6	PRN
9	)	)	-RRB-	_	8	P
10	affects	affect	VBZ	_	18	SBJ
11	the	the	DT	_	12	NMOD
12	incidence	incidence	NN	_	10	OBJ
13	of	of	IN	_	12	NMOD
14	CIA	cia	NN	_	13	PMOD
15	later	later	RB	_	12	TMP
16	in	in	IN	_	15	AMOD
17	life	life	NN	_	16	PMOD
18	has	have	VBZ	_	0	ROOT
19	,	,	,	_	18	P
20	to	to	IN	_	18	ADV
21	our	our	PRP$	_	22	NMOD
22	knowledge	knowledge	NN	_	20	PMOD
23	,	,	,	_	18	P
24	not	not	RB	_	18	ADV
25	previously	previously	RB	_	18	TMP
26	been	be	VBN	_	18	VC
27	studied	study	VBN	_	26	VC
28	.	.	.	_	18	P

1	Importantly	importantly	RB	_	4	ADV
2	,	,	,	_	4	P
3	RA	ra	NN	_	4	SBJ
4	occurs	occur	VBZ	_	0	ROOT
5	predominantly	predominantly	RB	_	4	ADV
6	in	in	IN	_	4	LOC
7	women	woman	NNS	_	6	PMOD
8	,	,	,	_	7	P
9	many	many	JJ	_	12	SBJ
10	of	of	IN	_	9	NMOD
11	which	which	WDT	_	10	PMOD
12	have	have	VBP	_	7	NMOD
13	had	have	VBN	_	12	VC
14	several	several	JJ	_	15	NMOD
15	children	child	NNS	_	13	OBJ
16	,	,	,	_	4	P
17	and	and	CC	_	4	COORD
18	it	it	PRP	_	19	SBJ
19	is	be	VBZ	_	17	CONJ
20	therefore	therefore	RB	_	19	ADV
21	appropriate	appropriate	JJ	_	19	PRD
22	to	to	TO	_	19	OPRD
23	also	also	RB	_	22	ADV
24	mimic	mimic	VB	_	22	IM
25	this	this	DT	_	26	NMOD
26	situation	situation	NN	_	24	OBJ
27	using	use	VBG	_	24	MNR
28	animal	animal	NN	_	29	NMOD
29	models	model	NNS	_	27	OBJ
30	.	.	.	_	4	P

1	In	in	IN	_	6	ADV
2	the	the	DT	_	4	NMOD
3	present	present	JJ	_	4	NMOD
4	paper	paper	NN	_	1	PMOD
5	we	we	PRP	_	6	SBJ
6	have	have	VBP	_	0	ROOT
7	analyzed	analyze	VBN	_	6	VC
8	female	female	JJ	_	9	NMOD
9	mice	mouse	NNS	_	7	OBJ
10	that	that	WDT	_	12	SBJ
11	previously	previously	RB	_	12	TMP
12	had	have	VBD	_	9	NMOD
13	undergone	undergo	VBN	_	12	VC
14	a	a	DT	_	16	NMOD
15	reproductive	reproductive	JJ	_	16	NMOD
16	study	study	NN	_	13	OBJ
17	(	(	-LRB-	_	18	P
18	Liljander	liljander	NNP	_	7	CIT
19	M	m	NNP	_	18	DEP
20	,	,	,	_	18	P
21	Sällström	sällström	NNP	_	18	DEP
22	MA	ma	NNP	_	18	DEP
23	,	,	,	_	18	P
24	Andersson	andersson	NNP	_	18	DEP
25	S	s	NNP	_	18	DEP
26	,	,	,	_	18	P
27	Wernhoff	wernhoff	NNP	_	18	DEP
28	P	p	NNP	_	18	DEP
29	,	,	,	_	18	P
30	Andersson	andersson	NNP	_	18	DEP
31	Å	å	NNP	_	18	DEP
32	,	,	,	_	18	P
33	Holmdahl	holmdahl	NNP	_	18	DEP
34	R	r	NNP	_	18	DEP
35	,	,	,	_	18	P
36	Mattsson	mattsson	NNP	_	18	DEP
37	R	r	NNP	_	18	DEP
38	,	,	,	_	18	P
39	unpublished	unpublished	JJ	_	18	DEP
40	data	datum	NNS	_	18	DEP
41	)	)	-RRB-	_	18	P
42	.	.	.	_	6	P

1	A	a	DT	_	2	NMOD
2	total	total	NN	_	28	SBJ
3	of	of	IN	_	2	NMOD
4	200	0	CD	_	6	NMOD
5	female	female	JJ	_	6	NMOD
6	mice	mouse	NNS	_	3	PMOD
7	(	(	-LRB-	_	9	P
8	ten	ten	CD	_	9	NMOD
9	months	month	NNS	_	6	PRN
10	of	of	IN	_	9	NMOD
11	age	age	NN	_	10	PMOD
12	)	)	-RRB-	_	9	P
13	of	of	IN	_	6	NMOD
14	the	the	DT	_	16	NMOD
15	N2	n0	NN	_	16	NMOD
16	backcross	backcross	NN	_	13	PMOD
17	between	between	IN	_	16	NMOD
18	NFR	nfr	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	N	n	NN	_	17	PMOD
21	and	and	CC	_	20	COORD
22	C57BL	c0bl	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	B10.Q	b0.q	NN	_	21	CONJ
25	(	(	-LRB-	_	26	P
26	B10.Q	b0.q	NN	_	20	PRN
27	)	)	-RRB-	_	26	P
28	were	be	VBD	_	0	ROOT
29	used	use	VBN	_	28	VC
30	to	to	TO	_	29	PRP
31	analyze	analyze	VB	_	30	IM
32	the	the	DT	_	34	NMOD
33	genetic	genetic	JJ	_	34	NMOD
34	control	control	NN	_	31	OBJ
35	of	of	IN	_	34	NMOD
36	CIA	cia	NN	_	35	PMOD
37	in	in	IN	_	31	LOC
38	aged	aged	JJ	_	39	NMOD
39	females	female	NNS	_	37	PMOD
40	with	with	IN	_	39	NMOD
41	a	a	DT	_	43	NMOD
42	multiparous	multiparous	JJ	_	43	NMOD
43	history	history	NN	_	40	PMOD
44	.	.	.	_	28	P

1	Materials	material	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	methods	method	NNS	_	2	CONJ

1	Mice	mouse	NNS	_	0	ROOT

1	Inbred	inbreed	VBN	_	5	NMOD
2	NFR	nfr	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	N	n	NN	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	originally	originally	RB	_	6	TMP
8	obtained	obtain	VBN	_	6	VC
9	from	from	IN	_	8	ADV
10	the	the	DT	_	12	NMOD
11	National	national	NNP	_	12	NMOD
12	Institute	institute	NNP	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	Health	health	NNP	_	13	PMOD
15	(	(	-LRB-	_	16	P
16	Bethesda	bethesda	NNP	_	12	PRN
17	,	,	,	_	16	P
18	MD	md	NNP	_	16	APPO
19	,	,	,	_	18	P
20	USA	usa	NNP	_	18	APPO
21	)	)	-RRB-	_	16	P
22	and	and	CC	_	6	COORD
23	the	the	DT	_	25	NMOD
24	B10.Q	b0.q	NN	_	25	NMOD
25	mice	mouse	NNS	_	26	SBJ
26	were	be	VBD	_	22	CONJ
27	originally	originally	RB	_	26	TMP
28	bought	buy	VBN	_	26	VC
29	from	from	IN	_	28	ADV
30	The	the	DT	_	32	NMOD
31	Jackson	jackson	NNP	_	32	NMOD
32	Laboratory	laboratory	NNP	_	29	PMOD
33	(	(	-LRB-	_	35	P
34	Bar	bar	NNP	_	35	NMOD
35	Harbor	harbor	NNP	_	32	PRN
36	,	,	,	_	35	P
37	ME	me	NNP	_	35	APPO
38	,	,	,	_	37	P
39	USA	usa	NNP	_	37	APPO
40	)	)	-RRB-	_	35	P
41	.	.	.	_	6	P

1	(	(	-LRB-	_	9	P
2	B10Q	b0q	NN	_	6	NMOD
3	×	×	HYPH	_	2	P
4	NFR	nfr	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	N	n	NN	_	8	NMOD
7	)	)	-RRB-	_	6	P
8	F1	f0	NN	_	9	NMOD
9	hybrids	hybrid	NNS	_	22	SBJ
10	and	and	CC	_	9	COORD
11	(	(	-LRB-	_	21	P
12	B10.Q	b0.q	NN	_	16	NMOD
13	×	×	SYM	_	16	P
14	NFR	nfr	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	N	n	NN	_	20	NMOD
17	)	)	-RRB-	_	20	P
18	×	×	SYM	_	20	P
19	B10.Q	b0.q	NN	_	20	NMOD
20	N2	n0	NN	_	21	NMOD
21	mice	mouse	NNS	_	10	CONJ
22	were	be	VBD	_	0	ROOT
23	bred	breed	VBN	_	22	VC
24	in	in	IN	_	23	MNR
25	individual	individual	JJ	_	27	NMOD
26	ventilated	ventilate	VBN	_	27	NMOD
27	cages	cage	NNS	_	24	PMOD
28	in	in	IN	_	23	LOC
29	the	the	DT	_	33	NMOD
30	BMC	bmc	NN	_	31	NMOD
31	Barrier	barrier	NN	_	33	NMOD
32	animal	animal	NN	_	33	NMOD
33	facility	facility	NN	_	28	PMOD
34	and	and	CC	_	28	COORD
35	at	at	IN	_	34	CONJ
36	the	the	DT	_	38	NMOD
37	animal	animal	NN	_	38	NMOD
38	house	house	NN	_	35	PMOD
39	of	of	IN	_	38	NMOD
40	the	the	DT	_	41	NMOD
41	Department	department	NNP	_	39	PMOD
42	of	of	IN	_	41	NMOD
43	Pathology	pathology	NNP	_	42	PMOD
44	,	,	,	_	41	P
45	Lund	lund	NNP	_	46	NMOD
46	University	university	NNP	_	41	APPO
47	,	,	,	_	46	P
48	Sweden	sweden	NNP	_	46	APPO
49	.	.	.	_	22	P

1	The	the	DT	_	2	NMOD
2	animals	animal	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	fed	feed	VBN	_	3	VC
5	ad	ad	FW	_	6	AMOD
6	libitum	libitum	FW	_	4	ADV
7	with	with	IN	_	4	MNR
8	standard	standard	JJ	_	10	NMOD
9	rodent	rodent	NN	_	10	NMOD
10	chow	chow	NN	_	7	PMOD
11	(	(	-LRB-	_	25	P
12	LAB	lab	NN	_	14	NMOD
13	FOR	for	NN	_	14	NMOD
14	R36	r0	NN	_	25	DEP
15	,	,	,	_	25	P
16	irradiated	irradiate	VBN	_	18	NMOD
17	breeding	breed	VBG	_	18	NMOD
18	food	food	NN	_	25	DEP
19	for	for	IN	_	18	NMOD
20	rats	rat	NNS	_	19	PMOD
21	and	and	CC	_	20	COORD
22	mice	mouse	NNS	_	21	CONJ
23	;	;	:	_	25	P
24	Lactamin	lactamin	NNP	_	25	NMOD
25	AB	ab	NNP	_	10	PRN
26	,	,	,	_	25	P
27	Stockholm	stockholm	NNP	_	25	APPO
28	,	,	,	_	27	P
29	Sweden	sweden	NNP	_	27	APPO
30	)	)	-RRB-	_	25	P
31	and	and	CC	_	10	COORD
32	water	water	NN	_	31	CONJ
33	in	in	IN	_	4	TMP
34	a	a	DT	_	35	NMOD
35	photoperiod	photoperiod	NN	_	33	PMOD
36	of	of	IN	_	35	NMOD
37	12	0	CD	_	38	NMOD
38	hours	hour	NNS	_	42	NMOD
39	:	:	SYM	_	41	P
40	12	0	CD	_	41	NMOD
41	hours	hour	NNS	_	38	NMOD
42	light	light	NN	_	36	PMOD
43	:	:	SYM	_	44	P
44	dark	dark	NN	_	42	NMOD
45	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	mice	mouse	NNS	_	8	SBJ
3	used	use	VBN	_	2	NMOD
4	in	in	IN	_	3	ADV
5	the	the	DT	_	7	NMOD
6	present	present	JJ	_	7	NMOD
7	study	study	NN	_	4	PMOD
8	had	have	VBD	_	0	ROOT
9	clean	clean	JJ	_	12	NMOD
10	health	health	NN	_	11	NMOD
11	monitoring	monitoring	NN	_	12	NMOD
12	protocols	protocol	NNS	_	8	OBJ
13	according	accord	VBG	_	8	ADV
14	to	to	IN	_	13	PMOD
15	the	the	DT	_	16	NMOD
16	Federation	federation	NNP	_	22	NMOD
17	of	of	IN	_	16	NMOD
18	European	european	NNP	_	21	NMOD
19	Laboratory	laboratory	NNP	_	20	NMOD
20	Animal	animal	NNP	_	21	NMOD
21	Sciences	science	NNP	_	17	PMOD
22	Association	association	NNP	_	23	NMOD
23	recommendations	recommendation	NNS	_	14	PMOD
24	.	.	.	_	8	P

1	Ethical	ethical	JJ	_	2	NMOD
2	permissions	permission	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	M125	m0	NN	_	3	PRD
5	-	-	HYPH	_	4	P
6	04	0	CD	_	4	NMOD
7	(	(	-LRB-	_	9	P
8	embryo	embryo	NN	_	9	NMOD
9	transfer	transfer	NN	_	4	PRN
10	)	)	-RRB-	_	9	P
11	and	and	CC	_	4	COORD
12	M290	m0	NN	_	11	CONJ
13	-	-	HYPH	_	12	P
14	03	0	CD	_	12	NMOD
15	(	(	-LRB-	_	16	P
16	reproduction	reproduction	NN	_	12	PRN
17	and	and	CC	_	16	COORD
18	arthritis	arthritis	NN	_	17	CONJ
19	)	)	-RRB-	_	16	P
20	.	.	.	_	3	P

1	Experimental	experimental	JJ	_	2	NMOD
2	design	design	NN	_	0	ROOT

1	A	a	DT	_	2	NMOD
2	total	total	NN	_	25	SBJ
3	of	of	IN	_	2	NMOD
4	200	0	CD	_	6	NMOD
5	female	female	JJ	_	6	NMOD
6	mice	mouse	NNS	_	3	PMOD
7	(	(	-LRB-	_	6	P
8	approximately	approximately	RB	_	9	QMOD
9	ten	ten	CD	_	10	NMOD
10	months	month	NNS	_	11	AMOD
11	old	old	JJ	_	6	NMOD
12	)	)	-RRB-	_	6	P
13	of	of	IN	_	6	NMOD
14	N2	n0	NN	_	15	NMOD
15	backcross	backcross	NN	_	24	NMOD
16	(	(	-LRB-	_	24	P
17	B10.Q	b0.q	NN	_	21	NMOD
18	×	×	HYPH	_	17	P
19	NFR	nfr	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	N	n	NN	_	24	NMOD
22	)	)	-RRB-	_	24	P
23	×	×	HYPH	_	21	P
24	B10.Q	b0.q	NN	_	13	PMOD
25	were	be	VBD	_	0	ROOT
26	used	use	VBN	_	25	VC
27	.	.	.	_	25	P

1	The	the	DT	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	had	have	VBD	_	0	ROOT
4	earlier	earlier	RBR	_	3	TMP
5	undergone	undergo	VBN	_	3	ADV
6	a	a	DT	_	8	NMOD
7	reproductive	reproductive	JJ	_	8	NMOD
8	study	study	NN	_	5	PMOD
9	where	where	WRB	_	12	LOC
10	each	each	DT	_	11	NMOD
11	animal	animal	NN	_	12	SBJ
12	had	have	VBD	_	8	NMOD
13	four	four	CD	_	15	NMOD
14	mating	mating	NN	_	15	NMOD
15	opportunities	opportunity	NNS	_	12	OBJ
16	.	.	.	_	3	P

1	First	$#ORD#$	RB	_	6	TMP
2	,	,	,	_	6	P
3	the	the	DT	_	5	NMOD
4	female	female	JJ	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	allowed	allow	VBN	_	6	VC
8	to	to	TO	_	7	OPRD
9	mate	mate	VB	_	8	IM
10	twice	twice	RB	_	9	TMP
11	with	with	IN	_	9	ADV
12	B10.RIII	b0.riii	NN	_	13	NMOD
13	males	male	NNS	_	11	PMOD
14	(	(	-LRB-	_	16	P
15	allogeneic	allogeneic	JJ	_	16	NMOD
16	mating	mating	NN	_	9	PRN
17	by	by	IN	_	16	NMOD
18	means	mean	NNS	_	17	PMOD
19	of	of	IN	_	18	NMOD
20	MHC	mhc	NN	_	24	NMOD
21	(	(	-LRB-	_	24	P
22	major	major	JJ	_	24	NMOD
23	histocompatibility	histocompatibility	NN	_	24	NMOD
24	complex	complex	NN	_	19	PMOD
25	)	)	-RRB-	_	16	P
26	and	and	CC	_	8	COORD
27	finally	finally	RB	_	28	ADV
28	to	to	TO	_	26	CONJ
29	mate	mate	VB	_	28	IM
30	twice	twice	RB	_	29	TMP
31	with	with	IN	_	29	ADV
32	B10.Q	b0.q	NN	_	33	NMOD
33	males	male	NNS	_	31	PMOD
34	(	(	-LRB-	_	36	P
35	syngeneic	syngeneic	JJ	_	36	NMOD
36	mating	mating	NN	_	29	PRN
37	by	by	IN	_	36	NMOD
38	means	mean	NNS	_	37	PMOD
39	of	of	IN	_	38	NMOD
40	MHC	mhc	NN	_	39	PMOD
41	)	)	-RRB-	_	36	P
42	.	.	.	_	6	P

1	After	after	IN	_	6	TMP
2	four	four	CD	_	4	NMOD
3	possible	possible	JJ	_	4	NMOD
4	pregnancies	pregnancy	NNS	_	1	PMOD
5	CIA	cia	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	induced	induce	VBN	_	6	VC
8	to	to	IN	_	7	ADV
9	the	the	DT	_	11	NMOD
10	female	female	JJ	_	11	NMOD
11	mice	mouse	NNS	_	8	PMOD
12	.	.	.	_	6	P

1	Induction	induction	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	evaluation	evaluation	NN	_	2	CONJ
4	of	of	IN	_	1	NMOD
5	CIA	cia	NN	_	4	PMOD

1	To	to	TO	_	7	PRP
2	induce	induce	VB	_	1	IM
3	CIA	cia	NN	_	2	OBJ
4	,	,	,	_	7	P
5	the	the	DT	_	6	NMOD
6	mice	mouse	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	immunized	immunize	VBN	_	7	VC
9	subcutaneously	subcutaneously	RB	_	8	MNR
10	at	at	IN	_	8	LOC
11	the	the	DT	_	12	NMOD
12	base	base	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	15	NMOD
15	tail	tail	NN	_	13	PMOD
16	with	with	IN	_	8	MNR
17	100	0	CD	_	18	NMOD
18	μg	μg	NN	_	21	NMOD
19	rat	rat	NN	_	21	NMOD
20	collagen	collagen	NN	_	21	NMOD
21	type	type	NN	_	16	PMOD
22	II	ii	CD	_	21	NMOD
23	(	(	-LRB-	_	24	P
24	CII	cii	NN	_	21	PRN
25	)	)	-RRB-	_	24	P
26	emulsified	emulsify	VBN	_	21	NMOD
27	in	in	IN	_	26	ADV
28	0.1	0	CD	_	29	NMOD
29	M	m	NN	_	31	NMOD
30	acetic	acetic	JJ	_	31	NMOD
31	acid	acid	NN	_	27	PMOD
32	combined	combine	VBN	_	31	NMOD
33	with	with	IN	_	32	ADV
34	an	an	DT	_	36	NMOD
35	equal	equal	JJ	_	36	NMOD
36	amount	amount	NN	_	33	PMOD
37	of	of	IN	_	36	NMOD
38	complete	complete	JJ	_	41	NMOD
39	Freud	freud	NNP	_	41	NMOD
40	's	's	POS	_	39	NMOD
41	adjuvant	adjuvant	NN	_	37	PMOD
42	(	(	-LRB-	_	44	P
43	Difco	difco	NNP	_	44	NMOD
44	Laboratories	laboratory	NNP	_	41	PRN
45	,	,	,	_	44	P
46	Detroit	detroit	NNP	_	44	APPO
47	,	,	,	_	46	P
48	MI	mi	NNP	_	46	APPO
49	,	,	,	_	48	P
50	USA	usa	NNP	_	48	APPO
51	)	)	-RRB-	_	44	P
52	.	.	.	_	7	P

1	A	a	DT	_	3	NMOD
2	booster	booster	NN	_	3	NMOD
3	injection	injection	NN	_	28	SBJ
4	containing	contain	VBG	_	3	NMOD
5	50	0	CD	_	6	NMOD
6	μg	μg	NN	_	7	NMOD
7	CII	cii	NN	_	4	OBJ
8	emulsified	emulsify	VBN	_	7	NMOD
9	in	in	IN	_	8	ADV
10	0.1	0	CD	_	11	NMOD
11	M	m	NN	_	13	NMOD
12	acetic	acetic	JJ	_	13	NMOD
13	acid	acid	NN	_	9	PMOD
14	combined	combine	VBN	_	13	NMOD
15	with	with	IN	_	14	ADV
16	an	an	DT	_	18	NMOD
17	equal	equal	JJ	_	18	NMOD
18	amount	amount	NN	_	15	PMOD
19	of	of	IN	_	18	NMOD
20	Freud	freud	NNP	_	23	NMOD
21	's	's	POS	_	20	NMOD
22	incomplete	incomplete	JJ	_	23	NMOD
23	adjuvant	adjuvant	NN	_	19	PMOD
24	(	(	-LRB-	_	26	P
25	Difco	difco	NNP	_	26	NMOD
26	Laboratories	laboratory	NNP	_	23	PRN
27	)	)	-RRB-	_	26	P
28	was	be	VBD	_	0	ROOT
29	given	give	VBN	_	28	VC
30	after	after	IN	_	29	TMP
31	30	0	CD	_	32	NMOD
32	days	day	NNS	_	30	PMOD
33	.	.	.	_	28	P

1	The	the	DT	_	3	NMOD
2	clinical	clinical	JJ	_	3	NMOD
3	scoring	scoring	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	arthritis	arthritis	NN	_	4	PMOD
6	commenced	commence	VBD	_	0	ROOT
7	25	0	CD	_	8	NMOD
8	days	day	NNS	_	9	ADV
9	after	after	IN	_	6	TMP
10	the	the	DT	_	12	NMOD
11	first	$#ORD#$	JJ	_	12	NMOD
12	immunization	immunization	NN	_	9	PMOD
13	.	.	.	_	6	P

1	Animals	animal	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	examined	examine	VBN	_	2	VC
4	for	for	IN	_	3	PRP
5	clinical	clinical	JJ	_	6	NMOD
6	signs	sign	NNS	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	CIA	cia	NN	_	7	PMOD
9	three	three	CD	_	10	NMOD
10	times	time	NNS	_	3	TMP
11	per	per	IN	_	10	NMOD
12	week	week	NN	_	11	PMOD
13	and	and	CC	_	2	COORD
14	were	be	VBD	_	13	CONJ
15	graded	grade	VBN	_	14	VC
16	on	on	IN	_	15	MNR
17	a	a	DT	_	21	NMOD
18	12	0	CD	_	20	NMOD
19	-	-	HYPH	_	18	P
20	point	point	NN	_	21	NMOD
21	scale	scale	NN	_	16	PMOD
22	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	arthritis	arthritis	NN	_	3	NMOD
3	index	index	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	assigned	assign	VBN	_	4	VC
6	to	to	IN	_	5	ADV
7	each	each	DT	_	8	NMOD
8	mouse	mouse	NN	_	6	PMOD
9	using	use	VBG	_	5	MNR
10	the	the	DT	_	12	NMOD
11	following	follow	VBG	_	12	NMOD
12	criteria	criterion	NNS	_	9	OBJ
13	:	:	:	_	4	P
14	0	0	CD	_	18	SBJ
15	=	=	SYM	_	18	P
16	no	no	DT	_	18	NMOD
17	visible	visible	JJ	_	18	NMOD
18	sign	sign	NN	_	4	DEP
19	of	of	IN	_	18	NMOD
20	arthritis	arthritis	NN	_	19	PMOD
21	,	,	,	_	18	P
22	1	0	CD	_	24	SBJ
23	=	=	SYM	_	24	P
24	redness	redness	NN	_	18	CONJ
25	and	and	CC	_	24	COORD
26	swelling	swelling	NN	_	25	CONJ
27	in	in	IN	_	24	LOC
28	a	a	DT	_	30	NMOD
29	single	single	JJ	_	30	NMOD
30	joint	joint	NN	_	27	PMOD
31	,	,	,	_	24	P
32	2	0	CD	_	34	SBJ
33	=	=	SYM	_	34	P
34	inflammation	inflammation	NN	_	24	CONJ
35	in	in	IN	_	34	LOC
36	multiple	multiple	JJ	_	37	NMOD
37	joints	joint	NNS	_	35	PMOD
38	,	,	,	_	34	P
39	and	and	CC	_	34	COORD
40	3	0	CD	_	43	SBJ
41	=	=	SYM	_	43	P
42	severe	severe	JJ	_	43	NMOD
43	inflammation	inflammation	NN	_	39	CONJ
44	in	in	IN	_	43	LOC
45	the	the	DT	_	47	NMOD
46	entire	entire	JJ	_	47	NMOD
47	paw	paw	NN	_	44	PMOD
48	and	and	CC	_	47	COORD
49	/	/	HYPH	_	48	P
50	or	or	CC	_	48	COORD
51	anklebone	anklebone	NN	_	48	CONJ
52	.	.	.	_	4	P

1	Each	each	DT	_	2	NMOD
2	paw	paw	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	given	give	VBN	_	3	VC
5	the	the	DT	_	6	NMOD
6	scores	score	NNS	_	7	NMOD
7	0	0	CD	_	4	OBJ
8	–	–	SYM	_	9	P
9	3	0	CD	_	7	NMOD
10	,	,	,	_	4	P
11	with	with	IN	_	4	ADV
12	the	the	DT	_	13	NMOD
13	index	index	NN	_	14	SBJ
14	being	be	VBG	_	11	PMOD
15	the	the	DT	_	16	NMOD
16	sum	sum	NN	_	14	PRD
17	of	of	IN	_	16	NMOD
18	all	all	DT	_	20	NMOD
19	four	four	CD	_	20	NMOD
20	paws	paw	NNS	_	17	PMOD
21	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	severity	severity	NN	_	3	NMOD
3	trait	trait	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	maximum	maximum	JJ	_	7	NMOD
7	score	score	NN	_	4	PRD
8	observed	observe	VBN	_	7	NMOD
9	in	in	IN	_	8	LOC
10	each	each	DT	_	12	NMOD
11	individual	individual	JJ	_	12	NMOD
12	female	female	NN	_	9	PMOD
13	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	onset	onset	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	number	number	NN	_	3	PRD
6	of	of	IN	_	5	NMOD
7	days	day	NNS	_	6	PMOD
8	calculated	calculate	VBN	_	5	NMOD
9	from	from	IN	_	5	NMOD
10	the	the	DT	_	12	NMOD
11	first	$#ORD#$	JJ	_	12	NMOD
12	immunization	immunization	NN	_	9	PMOD
13	to	to	IN	_	9	PMOD
14	the	the	DT	_	17	NMOD
15	first	$#ORD#$	JJ	_	17	NMOD
16	clinical	clinical	JJ	_	17	NMOD
17	signs	sign	NNS	_	13	PMOD
18	of	of	IN	_	17	NMOD
19	arthritis	arthritis	NN	_	18	PMOD
20	excluding	exclude	VBG	_	8	ADV
21	unaffected	unaffected	JJ	_	22	NMOD
22	animals	animal	NNS	_	20	OBJ
23	.	.	.	_	3	P

1	Microsatellite	microsatellite	NN	_	2	NMOD
2	genotyping	genotyping	NN	_	0	ROOT
3	and	and	CC	_	2	COORD
4	linkage	linkage	NN	_	5	NMOD
5	analysis	analysis	NN	_	3	CONJ

1	Tail	tail	NN	_	2	NMOD
2	biopsies	biopsy	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	collected	collect	VBN	_	3	VC
5	from	from	IN	_	4	ADV
6	all	all	DT	_	8	NMOD
7	N2	n0	NN	_	8	NMOD
8	females	female	NNS	_	5	PMOD
9	and	and	CC	_	8	COORD
10	the	the	DT	_	12	NMOD
11	F0	f0	NN	_	12	NMOD
12	generation	generation	NN	_	9	CONJ
13	.	.	.	_	3	P

1	DNA	dna	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	isolated	isolate	VBN	_	2	VC
4	according	accord	VBG	_	3	MNR
5	to	to	IN	_	4	PMOD
6	a	a	DT	_	9	NMOD
7	previously	previously	RB	_	8	AMOD
8	described	describe	VBN	_	9	NMOD
9	protocol	protocol	NN	_	5	PMOD
10	[	[	-LRB-	_	11	P
11	12	0	CD	_	3	PRN
12	]	]	-RRB-	_	11	P
13	.	.	.	_	2	P

1	After	after	IN	_	26	TMP
2	screening	screening	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	parental	parental	JJ	_	5	NMOD
5	DNA	dna	NN	_	3	PMOD
6	with	with	IN	_	2	NMOD
7	approximately	approximately	RB	_	8	QMOD
8	450	0	CD	_	14	NMOD
9	mouse	mouse	NN	_	14	NMOD
10	fluorescence	fluorescence	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	labeled	label	VBN	_	14	NMOD
13	microsatellite	microsatellite	NN	_	14	NMOD
14	markers	marker	NNS	_	6	PMOD
15	(	(	-LRB-	_	16	P
16	INTERACTIVA	interactiva	NNP	_	14	PRN
17	,	,	,	_	16	P
18	Ulm	ulm	NNP	_	16	APPO
19	,	,	,	_	18	P
20	Germany	germany	NNP	_	18	APPO
21	)	)	-RRB-	_	16	P
22	,	,	,	_	26	P
23	125	0	CD	_	25	NMOD
24	informative	informative	JJ	_	25	NMOD
25	markers	marker	NNS	_	26	SBJ
26	were	be	VBD	_	0	ROOT
27	selected	select	VBN	_	26	VC
28	covering	cover	VBG	_	25	NMOD
29	the	the	DT	_	30	NMOD
30	genome	genome	NN	_	28	OBJ
31	.	.	.	_	26	P

1	Two	two	CD	_	8	NMOD
2	hundred	hundred	CD	_	1	QMOD
3	and	and	CC	_	2	COORD
4	thirty	thirty	CD	_	3	CONJ
5	-	-	HYPH	_	4	P
6	seven	seven	CD	_	1	QMOD
7	N2	n0	NN	_	8	NMOD
8	mice	mouse	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	genotyped	genotyped	VBN	_	9	VC
11	with	with	IN	_	10	MNR
12	markers	marker	NNS	_	11	PMOD
13	covering	cover	VBG	_	12	NMOD
14	all	all	DT	_	15	NMOD
15	chromosomes	chromosome	NNS	_	13	OBJ
16	except	except	IN	_	15	NMOD
17	for	for	IN	_	16	PMOD
18	the	the	DT	_	20	NMOD
19	Y	y	NN	_	20	NMOD
20	chromosome	chromosome	NN	_	17	PMOD
21	.	.	.	_	9	P

1	PCR	pcr	NN	_	2	NMOD
2	amplification	amplification	NN	_	6	SBJ
3	for	for	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	markers	marker	NNS	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	performed	perform	VBN	_	6	VC
8	in	in	IN	_	7	MNR
9	a	a	DT	_	11	NMOD
10	final	final	JJ	_	11	NMOD
11	volume	volume	NN	_	8	PMOD
12	of	of	IN	_	11	NMOD
13	10	0	CD	_	14	NMOD
14	μl	μl	NN	_	12	PMOD
15	in	in	IN	_	7	MNR
16	a	a	DT	_	24	NMOD
17	96	0	CD	_	19	NMOD
18	-	-	HYPH	_	17	P
19	well	well	NN	_	24	NMOD
20	V	v	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	bottom	bottom	NN	_	24	NMOD
23	microtiter	microtiter	NN	_	24	NMOD
24	plate	plate	NN	_	15	PMOD
25	using	use	VBG	_	7	MNR
26	20	0	CD	_	27	NMOD
27	ng	ng	NN	_	28	NMOD
28	DNA	dna	NN	_	25	OBJ
29	,	,	,	_	28	P
30	10	0	CD	_	31	NMOD
31	mM	mm	NN	_	32	NMOD
32	KCl	kcl	NN	_	28	CONJ
33	,	,	,	_	32	P
34	20	0	CD	_	35	NMOD
35	mM	mm	NN	_	38	NMOD
36	Tris	tris	NN	_	38	NMOD
37	–	–	HYPH	_	36	P
38	HCl	hcl	NN	_	32	CONJ
39	,	,	,	_	38	P
40	10	0	CD	_	41	NMOD
41	mM	mm	NN	_	45	NMOD
42	(	(	-LRB-	_	43	P
43	NH4	nh0	NN	_	41	PRN
44	)	)	-RRB-	_	43	P
45	2SO4	0so0	NN	_	38	CONJ
46	,	,	,	_	45	P
47	2	0	CD	_	48	NMOD
48	mM	mm	NN	_	49	NMOD
49	MgCl2	mgcl0	NN	_	45	CONJ
50	,	,	,	_	49	P
51	0.1	0	CD	_	52	NMOD
52	%	%	NN	_	54	NMOD
53	Triton	triton	NN	_	54	NMOD
54	X	x	NN	_	49	CONJ
55	-	-	HYPH	_	54	P
56	100	0	CD	_	54	NMOD
57	,	,	,	_	54	P
58	pH	ph	NN	_	54	APPO
59	8.8	0	CD	_	58	NMOD
60	(	(	-LRB-	_	64	P
61	New	new	NNP	_	62	NMOD
62	England	england	NNP	_	64	NMOD
63	BioLabs	biolabs	NNP	_	64	NMOD
64	Inc.	inc.	NNP	_	54	PRN
65	,	,	,	_	64	P
66	Ipswich	ipswich	NNP	_	64	APPO
67	,	,	,	_	66	P
68	MA	ma	NNP	_	66	APPO
69	,	,	,	_	68	P
70	USA	usa	NNP	_	68	APPO
71	)	)	-RRB-	_	64	P
72	,	,	,	_	54	P
73	3	0	CD	_	74	NMOD
74	μM	μm	NN	_	80	NMOD
75	(	(	-LRB-	_	77	P
76	10	0	CD	_	77	NMOD
77	pmol	pmol	NN	_	74	PRN
78	)	)	-RRB-	_	77	P
79	each	each	DT	_	80	NMOD
80	primer	primer	NN	_	54	CONJ
81	,	,	,	_	80	P
82	2	0	CD	_	83	NMOD
83	mM	mm	NN	_	84	NMOD
84	dNTPs	dntps	NNS	_	80	CONJ
85	(	(	-LRB-	_	87	P
86	Advanced	advanced	NNP	_	87	NMOD
87	Biotechnologies	biotechnology	NNP	_	84	PRN
88	,	,	,	_	87	P
89	Epsom	epsom	NNP	_	87	APPO
90	,	,	,	_	89	P
91	Surrey	surrey	NNP	_	89	APPO
92	,	,	,	_	91	P
93	UK	uk	NNP	_	91	APPO
94	)	)	-RRB-	_	87	P
95	and	and	CC	_	84	COORD
96	0.25	0	CD	_	97	NMOD
97	U	u	NN	_	100	NMOD
98	Taq	taq	NN	_	100	NMOD
99	DNA	dna	NN	_	100	NMOD
100	Polymerase	polymerase	NN	_	95	CONJ
101	(	(	-LRB-	_	105	P
102	New	new	NNP	_	103	NMOD
103	England	england	NNP	_	105	NMOD
104	BioLabs	biolabs	NNP	_	105	NMOD
105	Inc.	inc.	NNP	_	100	PRN
106	)	)	-RRB-	_	105	P
107	.	.	.	_	6	P

1	The	the	DT	_	3	NMOD
2	following	follow	VBG	_	3	NMOD
3	program	program	NN	_	4	SBJ
4	was	be	VBD	_	11	DEP
5	used	use	VBN	_	4	VC
6	to	to	TO	_	5	PRP
7	amplify	amplify	VB	_	6	IM
8	the	the	DT	_	9	NMOD
9	DNA	dna	NN	_	7	OBJ
10	:	:	:	_	11	P
11	denaturation	denaturation	NN	_	0	ROOT
12	at	at	IN	_	11	NMOD
13	95	0	CD	_	14	NMOD
14	°C	°c	NN	_	12	PMOD
15	for	for	IN	_	11	TMP
16	3	0	CD	_	17	NMOD
17	minutes	minute	NNS	_	15	PMOD
18	,	,	,	_	11	P
19	annealing	anneal	VBG	_	11	CONJ
20	at	at	IN	_	19	NMOD
21	56	0	CD	_	22	NMOD
22	°C	°c	NN	_	20	PMOD
23	for	for	IN	_	19	TMP
24	45	0	CD	_	25	NMOD
25	seconds	second	NNS	_	23	PMOD
26	,	,	,	_	19	P
27	polymerization	polymerization	NN	_	19	CONJ
28	at	at	IN	_	27	NMOD
29	72	0	CD	_	30	NMOD
30	°C	°c	NN	_	28	PMOD
31	for	for	IN	_	27	TMP
32	1	0	CD	_	33	NMOD
33	minute	minute	NN	_	31	PMOD
34	,	,	,	_	27	P
35	30	0	CD	_	36	NMOD
36	cycles	cycle	NNS	_	27	CONJ
37	of	of	IN	_	36	NMOD
38	95	0	CD	_	39	NMOD
39	°C	°c	NN	_	37	PMOD
40	for	for	IN	_	39	TMP
41	30	0	CD	_	42	NMOD
42	seconds	second	NNS	_	40	PMOD
43	,	,	,	_	39	P
44	56	0	CD	_	45	NMOD
45	°C	°c	NN	_	39	CONJ
46	for	for	IN	_	45	TMP
47	45	0	CD	_	48	NMOD
48	seconds	second	NNS	_	46	PMOD
49	and	and	CC	_	45	COORD
50	72	0	CD	_	51	NMOD
51	°C	°c	NN	_	49	CONJ
52	for	for	IN	_	51	TMP
53	1	0	CD	_	54	NMOD
54	minute	minute	NN	_	52	PMOD
55	,	,	,	_	36	P
56	and	and	CC	_	36	COORD
57	a	a	DT	_	60	NMOD
58	final	final	JJ	_	60	NMOD
59	extension	extension	NN	_	60	NMOD
60	step	step	NN	_	56	CONJ
61	of	of	IN	_	60	NMOD
62	7	0	CD	_	63	NMOD
63	minutes	minute	NNS	_	61	PMOD
64	at	at	IN	_	63	NMOD
65	72	0	CD	_	66	NMOD
66	°C	°c	NN	_	64	PMOD
67	.	.	.	_	11	P

1	The	the	DT	_	3	NMOD
2	PCR	pcr	NN	_	3	NMOD
3	products	product	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	analyzed	analyze	VBN	_	4	VC
6	on	on	IN	_	5	MNR
7	a	a	DT	_	8	NMOD
8	MegaBACE	megabace	NNP	_	6	PMOD
9	™	™	SYM	_	8	P
10	1000	0	CD	_	8	NMOD
11	(	(	-LRB-	_	15	P
12	Amersham	amersham	NNP	_	15	NMOD
13	Pharmacia	pharmacia	NNP	_	15	NMOD
14	Biotech	biotech	NNP	_	15	NMOD
15	Inc	inc	NNP	_	8	PRN
16	Piscataway	piscataway	NNP	_	15	LOC
17	,	,	,	_	16	P
18	NJ	nj	NNP	_	16	APPO
19	,	,	,	_	18	P
20	USA	usa	NNP	_	18	APPO
21	)	)	-RRB-	_	15	P
22	according	accord	VBG	_	5	MNR
23	to	to	IN	_	22	PMOD
24	the	the	DT	_	25	NMOD
25	manufacturer	manufacturer	NN	_	27	NMOD
26	's	's	POS	_	25	NMOD
27	protocol	protocol	NN	_	23	PMOD
28	.	.	.	_	4	P

1	Data	datum	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	analyzed	analyze	VBN	_	2	VC
4	with	with	IN	_	3	MNR
5	Genetic	genetic	JJ	_	6	NMOD
6	Profiler	profiler	NN	_	4	PMOD
7	1.1	0	CD	_	6	NMOD
8	(	(	-LRB-	_	12	P
9	Amersham	amersham	NNP	_	12	NMOD
10	Pharmacia	pharmacia	NNP	_	12	NMOD
11	Biotech	biotech	NNP	_	12	NMOD
12	Inc	inc	NNP	_	6	PRN
13	)	)	-RRB-	_	12	P
14	.	.	.	_	2	P

1	Map	map	NNP	_	3	NMOD
2	Manager	manager	NNP	_	3	NMOD
3	QTXb20	qtxb0	NNP	_	5	NMOD
4	free	free	JJ	_	5	NMOD
5	software	software	NN	_	9	SBJ
6	[	[	-LRB-	_	7	P
7	13	0	CD	_	5	PRN
8	]	]	-RRB-	_	7	P
9	was	be	VBD	_	0	ROOT
10	used	use	VBN	_	9	VC
11	to	to	TO	_	10	PRP
12	perform	perform	VB	_	11	IM
13	linkage	linkage	NN	_	14	NMOD
14	analysis	analysis	NN	_	12	OBJ
15	and	and	CC	_	14	COORD
16	the	the	DT	_	18	NMOD
17	permutation	permutation	NN	_	18	NMOD
18	test	test	NN	_	15	CONJ
19	.	.	.	_	9	P

1	Ninety	ninety	CD	_	2	NMOD
2	percent	percent	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	mouse	mouse	NN	_	6	NMOD
6	genome	genome	NN	_	3	PMOD
7	was	be	VBD	_	0	ROOT
8	within	within	IN	_	7	LOC
9	a	a	DT	_	13	NMOD
10	20	0	CD	_	11	NMOD
11	cM	cm	NN	_	13	NMOD
12	intermarker	intermarker	NN	_	13	NMOD
13	distance	distance	NN	_	8	PMOD
14	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	marker	marker	NN	_	3	NMOD
3	map	map	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	generated	generate	VBN	_	4	VC
6	using	use	VBG	_	5	MNR
7	the	the	DT	_	10	NMOD
8	Kosambis	kosambis	NNP	_	10	NMOD
9	map	map	NN	_	10	NMOD
10	function	function	NN	_	6	OBJ
11	and	and	CC	_	4	COORD
12	1,000	0	CD	_	13	NMOD
13	permutations	permutation	NNS	_	14	SBJ
14	were	be	VBD	_	11	CONJ
15	performed	perform	VBN	_	14	VC
16	for	for	IN	_	15	ADV
17	every	every	DT	_	18	NMOD
18	phenotype	phenotype	NN	_	16	PMOD
19	(	(	-LRB-	_	22	P
20	P	p	NN	_	22	SBJ
21	<	<	SYM	_	22	P
22	0.05	0	CD	_	15	PRN
23	)	)	-RRB-	_	22	P
24	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	permutation	permutation	NN	_	3	NMOD
3	tests	test	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	carried	carry	VBN	_	4	VC
6	out	out	RP	_	5	PRT
7	to	to	TO	_	5	PRP
8	establish	establish	VB	_	7	IM
9	empirical	empirical	JJ	_	10	NMOD
10	significance	significance	NN	_	11	NMOD
11	thresholds	threshold	NNS	_	8	OBJ
12	for	for	IN	_	8	ADV
13	the	the	DT	_	14	NMOD
14	interactions	interaction	NNS	_	12	PMOD
15	.	.	.	_	4	P

1	A	a	DT	_	2	NMOD
2	threshold	threshold	NN	_	15	SBJ
3	equal	equal	JJ	_	2	NMOD
4	to	to	IN	_	3	AMOD
5	or	or	CC	_	3	COORD
6	above	above	IN	_	5	CONJ
7	the	the	DT	_	9	NMOD
8	37th	$#ORD#$	JJ	_	9	NMOD
9	percentile	percentile	NN	_	6	PMOD
10	(	(	-LRB-	_	13	P
11	P	p	NN	_	13	SBJ
12	=	=	SYM	_	13	P
13	0.63	0	CD	_	2	PRN
14	)	)	-RRB-	_	13	P
15	was	be	VBD	_	0	ROOT
16	considered	consider	VBN	_	15	VC
17	suggestively	suggestively	RB	_	18	AMOD
18	significant	significant	JJ	_	16	OPRD
19	,	,	,	_	15	P
20	and	and	CC	_	15	COORD
21	the	the	DT	_	22	NMOD
22	level	level	NN	_	27	SBJ
23	for	for	IN	_	22	NMOD
24	the	the	DT	_	26	NMOD
25	significant	significant	JJ	_	26	NMOD
26	threshold	threshold	NN	_	23	PMOD
27	was	be	VBD	_	20	CONJ
28	set	set	VBN	_	27	VC
29	to	to	IN	_	28	ADV
30	the	the	DT	_	32	NMOD
31	95th	$#ORD#$	JJ	_	32	NMOD
32	percentile	percentile	NN	_	29	PMOD
33	(	(	-LRB-	_	36	P
34	P	p	NN	_	36	SBJ
35	=	=	SYM	_	36	P
36	0.05	0	CD	_	28	PRN
37	)	)	-RRB-	_	36	P
38	.	.	.	_	15	P

1	Interval	interval	JJ	_	2	NMOD
2	mapping	mapping	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	made	make	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	a	a	DT	_	9	NMOD
7	2	0	CD	_	8	NMOD
8	cM	cm	NN	_	9	NMOD
9	increase	increase	NN	_	5	PMOD
10	under	under	IN	_	4	ADV
11	the	the	DT	_	14	NMOD
12	additive	additive	JJ	_	14	NMOD
13	regression	regression	NN	_	14	NMOD
14	model	model	NN	_	10	PMOD
15	in	in	IN	_	4	PRP
16	order	order	NN	_	15	PMOD
17	to	to	TO	_	16	NMOD
18	calculate	calculate	VB	_	17	IM
19	the	the	DT	_	21	NMOD
20	test	test	NN	_	21	NMOD
21	statistics	statistic	NNS	_	18	OBJ
22	.	.	.	_	3	P

1	Enzyme	enzyme	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	linked	link	VBN	_	5	NMOD
4	immunosorbent	immunosorbent	NN	_	5	NMOD
5	assay	assay	NN	_	0	ROOT

1	The	the	DT	_	4	NMOD
2	adult	adult	JJ	_	4	NMOD
3	female	female	JJ	_	4	NMOD
4	mice	mouse	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	sacrificed	sacrifice	VBN	_	5	VC
7	at	at	IN	_	6	TMP
8	15	0	CD	_	9	NMOD
9	months	month	NNS	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	age	age	NN	_	10	PMOD
12	and	and	CC	_	5	COORD
13	sera	serum	NNS	_	14	SBJ
14	were	be	VBD	_	12	CONJ
15	collected	collect	VBN	_	14	VC
16	.	.	.	_	5	P

1	Anti-CII	anti-cii	JJ	_	3	NMOD
2	antibody	antibody	NN	_	3	NMOD
3	titers	titer	NNS	_	6	SBJ
4	in	in	IN	_	3	LOC
5	sera	serum	NNS	_	4	PMOD
6	were	be	VBD	_	0	ROOT
7	analyzed	analyze	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	a	a	DT	_	12	NMOD
10	sandwich	sandwich	NN	_	11	NMOD
11	ELISA	elisa	NN	_	12	NMOD
12	technique	technique	NN	_	8	PMOD
13	[	[	-LRB-	_	14	P
14	14	0	CD	_	7	PRN
15	]	]	-RRB-	_	14	P
16	.	.	.	_	6	P

1	In	in	IN	_	11	ADV
2	brief	brief	JJ	_	1	PMOD
3	,	,	,	_	11	P
4	CII	cii	NN	_	11	SBJ
5	(	(	-LRB-	_	7	P
6	10	0	CD	_	7	NMOD
7	μg	μg	NN	_	4	PRN
8	/	/	SYM	_	9	P
9	ml	ml	NN	_	7	NMOD
10	)	)	-RRB-	_	7	P
11	was	be	VBD	_	0	ROOT
12	coupled	couple	VBN	_	11	VC
13	to	to	IN	_	12	ADV
14	immunosorbent	immunosorbent	NN	_	15	NMOD
15	plates	plate	NNS	_	13	PMOD
16	overnight	overnight	RB	_	12	TMP
17	at	at	IN	_	12	ADV
18	4	0	CD	_	19	NMOD
19	°C	°c	NN	_	17	PMOD
20	.	.	.	_	11	P

1	Bovine	bovine	JJ	_	3	NMOD
2	serum	serum	NN	_	3	NMOD
3	albumin	albumin	NN	_	14	SBJ
4	(	(	-LRB-	_	6	P
5	Sigma	sigma	NNP	_	6	NMOD
6	Chemical	chemical	NNP	_	3	PRN
7	St	st	NNP	_	8	NMOD
8	Louis	louis	NNP	_	6	LOC
9	,	,	,	_	8	P
10	MO	mo	NNP	_	8	APPO
11	,	,	,	_	10	P
12	USA	usa	NNP	_	10	APPO
13	)	)	-RRB-	_	6	P
14	was	be	VBD	_	0	ROOT
15	used	use	VBN	_	14	VC
16	for	for	IN	_	15	PRP
17	blocking	blocking	NN	_	16	PMOD
18	,	,	,	_	14	P
19	and	and	CC	_	14	COORD
20	thereafter	thereafter	RB	_	41	ADV
21	different	different	JJ	_	22	NMOD
22	dilutions	dilution	NNS	_	41	SBJ
23	of	of	IN	_	22	NMOD
24	control	control	NN	_	25	NMOD
25	sera	serum	NNS	_	23	PMOD
26	(	(	-LRB-	_	30	P
27	purified	purify	VBN	_	30	NMOD
28	mouse	mouse	NN	_	30	NMOD
29	anti-CII	anti-cii	JJ	_	30	NMOD
30	antibodies	antibody	NNS	_	25	PRN
31	)	)	-RRB-	_	30	P
32	,	,	,	_	25	P
33	test	test	NN	_	34	NMOD
34	sera	serum	NNS	_	25	CONJ
35	,	,	,	_	34	P
36	and	and	CC	_	34	COORD
37	positive	positive	JJ	_	40	NMOD
38	and	and	CC	_	37	COORD
39	negative	negative	JJ	_	38	CONJ
40	controls	control	NNS	_	36	CONJ
41	were	be	VBD	_	19	CONJ
42	added	add	VBN	_	41	VC
43	.	.	.	_	14	P

1	The	the	DT	_	2	NMOD
2	presence	presence	NN	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	CII	cii	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	specific	specific	JJ	_	7	NMOD
7	IgG	igg	NN	_	3	PMOD
8	was	be	VBD	_	0	ROOT
9	visualized	visualize	VBN	_	8	VC
10	by	by	IN	_	9	MNR
11	means	mean	NNS	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	peroxidase	peroxidase	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	conjugated	conjugate	VBN	_	18	NMOD
16	goat	goat	NN	_	18	NMOD
17	antimouse	antimouse	JJ	_	18	NMOD
18	IgG	igg	NN	_	12	PMOD
19	.	.	.	_	8	P

1	Statistical	statistical	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	Statistical	statistical	JJ	_	2	NMOD
2	comparison	comparison	NN	_	8	SBJ
3	between	between	IN	_	2	NMOD
4	the	the	DT	_	7	NMOD
5	different	different	JJ	_	7	NMOD
6	experimental	experimental	JJ	_	7	NMOD
7	groups	group	NNS	_	3	PMOD
8	was	be	VBD	_	0	ROOT
9	performed	perform	VBN	_	8	VC
10	using	use	VBG	_	9	MNR
11	the	the	DT	_	16	NMOD
12	Mann	mann	NNP	_	14	NMOD
13	-	-	HYPH	_	12	P
14	Whitney	whitney	NNP	_	16	NMOD
15	U	u	NNP	_	16	NMOD
16	test	test	NN	_	10	OBJ
17	or	or	CC	_	16	COORD
18	Student	student	NNP	_	22	NMOD
19	's	's	POS	_	18	NMOD
20	unpaired	unpaired	JJ	_	22	NMOD
21	t	t	NN	_	22	NMOD
22	test	test	NN	_	17	CONJ
23	.	.	.	_	8	P

1	Results	result	NNS	_	0	ROOT

1	NFR	nfr	NN	_	3	NMOD
2	/	/	HYPH	_	1	P
3	N	n	NN	_	5	NMOD
4	female	female	JJ	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	show	show	VBP	_	0	ROOT
7	delayed	delay	VBN	_	8	NMOD
8	onset	onset	NN	_	6	OBJ
9	and	and	CC	_	8	COORD
10	lower	low	JJR	_	11	NMOD
11	incidence	incidence	NN	_	9	CONJ
12	of	of	IN	_	8	NMOD
13	CIA	cia	NN	_	12	PMOD
14	compared	compare	VBN	_	6	ADV
15	with	with	IN	_	14	PMOD
16	B10.Q	b0.q	NN	_	17	NMOD
17	females	female	NNS	_	15	PMOD

1	The	the	DT	_	2	NMOD
2	onset	onset	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	disease	disease	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	significantly	significantly	RB	_	6	ADV
8	delayed	delay	VBN	_	6	VC
9	in	in	IN	_	8	LOC
10	NFR	nfr	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	N	n	NN	_	13	NMOD
13	mice	mouse	NNS	_	9	PMOD
14	,	,	,	_	8	P
15	which	which	WDT	_	16	SBJ
16	resulted	result	VBD	_	8	ADV
17	in	in	IN	_	16	ADV
18	lower	low	JJR	_	19	NMOD
19	incidence	incidence	NN	_	17	PMOD
20	in	in	IN	_	16	TMP
21	the	the	DT	_	23	NMOD
22	initial	initial	JJ	_	23	NMOD
23	phase	phase	NN	_	20	PMOD
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	26	NMOD
26	disease	disease	NN	_	24	PMOD
27	(	(	-LRB-	_	28	P
28	Table	table	NN	_	16	PRN
29	1	0	CD	_	28	NMOD
30	and	and	CC	_	28	COORD
31	Figure	figure	NN	_	30	CONJ
32	1	0	CD	_	31	NMOD
33	)	)	-RRB-	_	28	P
34	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	appearance	appearance	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	arthritis	arthritis	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	slightly	slightly	RB	_	8	AMOD
8	different	different	JJ	_	6	PRD
9	between	between	IN	_	6	ADV
10	the	the	DT	_	12	NMOD
11	two	two	CD	_	12	NMOD
12	strains	strain	NNS	_	9	PMOD
13	,	,	,	_	6	P
14	NFR	nfr	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	N	n	NN	_	17	NMOD
17	mice	mouse	NNS	_	18	SBJ
18	showing	show	VBG	_	6	ADV
19	a	a	DT	_	21	NMOD
20	higher	high	JJR	_	21	NMOD
21	frequency	frequency	NN	_	18	OBJ
22	of	of	IN	_	21	NMOD
23	swelling	swelling	NN	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	27	NMOD
26	entire	entire	JJ	_	27	NMOD
27	paw	paw	NN	_	24	PMOD
28	than	than	IN	_	21	NMOD
29	B10.Q	b0.q	NN	_	30	NMOD
30	mice	mouse	NNS	_	28	PMOD
31	.	.	.	_	6	P

1	Later	later	RBR	_	16	TMP
2	in	in	IN	_	1	AMOD
3	the	the	DT	_	5	NMOD
4	disease	disease	NN	_	5	NMOD
5	course	course	NN	_	2	PMOD
6	the	the	DT	_	7	NMOD
7	differences	difference	NNS	_	16	SBJ
8	in	in	IN	_	7	NMOD
9	CIA	cia	NN	_	10	NMOD
10	frequency	frequency	NN	_	8	PMOD
11	and	and	CC	_	10	COORD
12	severity	severity	NN	_	11	CONJ
13	between	between	IN	_	10	NMOD
14	the	the	DT	_	15	NMOD
15	strains	strain	NNS	_	13	PMOD
16	were	be	VBD	_	0	ROOT
17	less	less	RBR	_	18	AMOD
18	obvious	obvious	JJ	_	16	PRD
19	.	.	.	_	16	P

1	However	however	RB	_	19	ADV
2	,	,	,	_	19	P
3	the	the	DT	_	5	NMOD
4	anti-CII	anti-cii	JJ	_	5	NMOD
5	titers	titer	NNS	_	19	SBJ
6	100	0	CD	_	7	NMOD
7	days	day	NNS	_	8	ADV
8	after	after	IN	_	19	TMP
9	primary	primary	JJ	_	10	NMOD
10	immunization	immunization	NN	_	8	PMOD
11	(	(	-LRB-	_	8	P
12	and	and	CC	_	8	COORD
13	70	0	CD	_	14	NMOD
14	days	day	NNS	_	15	ADV
15	after	after	IN	_	12	CONJ
16	the	the	DT	_	17	NMOD
17	booster	booster	NN	_	15	PMOD
18	)	)	-RRB-	_	19	P
19	differed	differ	VBD	_	0	ROOT
20	significantly	significantly	RB	_	19	ADV
21	between	between	IN	_	19	ADV
22	NFR	nfr	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	N	n	NN	_	28	NMOD
25	and	and	CC	_	24	COORD
26	B10.Q	b0.q	NN	_	25	CONJ
27	female	female	JJ	_	28	NMOD
28	mice	mouse	NNS	_	21	PMOD
29	(	(	-LRB-	_	30	P
30	see	see	VB	_	19	PRN
31	Table	table	NN	_	30	OBJ
32	1	0	CD	_	31	NMOD
33	)	)	-RRB-	_	30	P
34	.	.	.	_	19	P

1	Pregnancy	pregnancy	NN	_	2	NMOD
2	history	history	NN	_	3	SBJ
3	does	do	VBZ	_	0	ROOT
4	not	not	RB	_	3	ADV
5	significantly	significantly	RB	_	3	ADV
6	affect	affect	VB	_	3	VC
7	incidence	incidence	NN	_	6	OBJ
8	or	or	CC	_	7	COORD
9	severity	severity	NN	_	8	CONJ
10	of	of	IN	_	7	NMOD
11	CIA	cia	NN	_	10	PMOD
12	in	in	IN	_	6	LOC
13	female	female	JJ	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	mixed	mixed	JJ	_	18	NMOD
17	genetic	genetic	JJ	_	18	NMOD
18	background	background	NN	_	15	PMOD

1	Table	table	NN	_	3	SBJ
2	2	0	CD	_	1	NMOD
3	presents	present	VBZ	_	0	ROOT
4	the	the	DT	_	5	NMOD
5	results	result	NNS	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	arthritic	arthritic	JJ	_	8	NMOD
8	incidence	incidence	NN	_	6	PMOD
9	,	,	,	_	8	P
10	arthritis	arthritis	NN	_	11	NMOD
11	onset	onset	NN	_	8	CONJ
12	and	and	CC	_	11	COORD
13	maximum	maximum	JJ	_	15	NMOD
14	arthritic	arthritic	JJ	_	15	NMOD
15	score	score	NN	_	12	CONJ
16	for	for	IN	_	8	NMOD
17	the	the	DT	_	19	NMOD
18	female	female	JJ	_	19	NMOD
19	mice	mouse	NNS	_	16	PMOD
20	of	of	IN	_	19	NMOD
21	the	the	DT	_	23	NMOD
22	N2	n0	NN	_	23	NMOD
23	generation	generation	NN	_	20	PMOD
24	,	,	,	_	19	P
25	(	(	-LRB-	_	30	P
26	NFR	nfr	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	N	n	NN	_	30	NMOD
29	×	×	HYPH	_	28	P
30	B10.Q	b0.q	NN	_	33	NMOD
31	)	)	-RRB-	_	30	P
32	×	×	HYPH	_	30	P
33	B10.Q	b0.q	NN	_	19	APPO
34	,	,	,	_	19	P
35	grouped	group	VBN	_	19	NMOD
36	according	accord	VBG	_	35	MNR
37	to	to	IN	_	36	PMOD
38	the	the	DT	_	39	NMOD
39	number	number	NN	_	37	PMOD
40	of	of	IN	_	39	NMOD
41	pregnancies	pregnancy	NNS	_	40	PMOD
42	they	they	PRP	_	43	SBJ
43	had	have	VBD	_	39	NMOD
44	experienced	experience	VBN	_	43	VC
45	prior	prior	JJ	_	46	PMOD
46	to	to	IN	_	44	TMP
47	immunization	immunization	NN	_	46	PMOD
48	with	with	IN	_	47	NMOD
49	CII	cii	NN	_	48	PMOD
50	.	.	.	_	3	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	PRD
6	in	in	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	incidence	incidence	NN	_	6	PMOD
9	or	or	CC	_	8	COORD
10	severity	severity	NN	_	9	CONJ
11	of	of	IN	_	8	NMOD
12	arthritis	arthritis	NN	_	11	PMOD
13	depending	depend	VBG	_	2	ADV
14	on	on	IN	_	13	PMOD
15	the	the	DT	_	16	NMOD
16	number	number	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	pregnancies	pregnancy	NNS	_	17	PMOD
19	that	that	WDT	_	20	SBJ
20	had	have	VBD	_	18	NMOD
21	been	be	VBN	_	20	VC
22	passed	pass	VBN	_	21	VC
23	prior	prior	JJ	_	24	PMOD
24	to	to	IN	_	22	TMP
25	the	the	DT	_	26	NMOD
26	induction	induction	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	the	the	DT	_	29	NMOD
29	disease	disease	NN	_	27	PMOD
30	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	observed	observe	VBD	_	0	ROOT
3	a	a	DT	_	4	NMOD
4	trend	trend	NN	_	2	OBJ
5	towards	towards	IN	_	4	NMOD
6	lower	low	JJR	_	7	NMOD
7	severity	severity	NN	_	5	PMOD
8	in	in	IN	_	4	LOC
9	multiparous	multiparous	JJ	_	10	NMOD
10	mice	mouse	NNS	_	8	PMOD
11	compared	compare	VBN	_	4	NMOD
12	with	with	IN	_	11	PMOD
13	mice	mouse	NNS	_	12	PMOD
14	with	with	IN	_	13	NMOD
15	a	a	DT	_	16	NMOD
16	history	history	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	zero	zero	CD	_	21	NMOD
19	to	to	IN	_	18	QMOD
20	two	two	CD	_	18	QMOD
21	pregnancies	pregnancy	NNS	_	17	PMOD
22	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	onset	onset	NN	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	diseases	disease	NNS	_	3	PMOD
5	,	,	,	_	8	P
6	however	however	RB	_	8	ADV
7	,	,	,	_	8	P
8	was	be	VBD	_	0	ROOT
9	earlier	early	JJR	_	8	PRD
10	in	in	IN	_	8	LOC
11	mice	mouse	NNS	_	10	PMOD
12	that	that	WDT	_	13	SBJ
13	had	have	VBD	_	11	NMOD
14	passed	pass	VBN	_	13	VC
15	more	more	JJR	_	18	NMOD
16	than	than	IN	_	15	QMOD
17	one	one	CD	_	15	QMOD
18	pregnancy	pregnancy	NN	_	14	OBJ
19	.	.	.	_	8	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	4	NMOD
4	difference	difference	NN	_	2	PRD
5	in	in	IN	_	4	NMOD
6	the	the	DT	_	7	NMOD
7	development	development	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	disease	disease	NN	_	8	PMOD
11	between	between	IN	_	4	NMOD
12	female	female	JJ	_	13	NMOD
13	mice	mouse	NNS	_	11	PMOD
14	that	that	WDT	_	15	SBJ
15	have	have	VBP	_	13	NMOD
16	only	only	RB	_	15	ADV
17	been	be	VBN	_	15	VC
18	pregnant	pregnant	JJ	_	17	PRD
19	with	with	IN	_	18	AMOD
20	MHC	mhc	NN	_	21	AMOD
21	mismatched	mismatch	VBN	_	22	NMOD
22	males	male	NNS	_	19	PMOD
23	(	(	-LRB-	_	24	P
24	B10.RIII	b0.riii	NN	_	22	PRN
25	)	)	-RRB-	_	24	P
26	and	and	CC	_	13	COORD
27	female	female	JJ	_	28	NMOD
28	mice	mouse	NNS	_	26	CONJ
29	that	that	WDT	_	31	SBJ
30	only	only	RB	_	31	ADV
31	have	have	VBP	_	28	NMOD
32	been	be	VBN	_	31	VC
33	pregnant	pregnant	JJ	_	32	PRD
34	with	with	IN	_	33	AMOD
35	MHC	mhc	NN	_	36	AMOD
36	matched	match	VBN	_	37	NMOD
37	males	male	NNS	_	34	PMOD
38	(	(	-LRB-	_	39	P
39	B10.Q	b0.q	NN	_	37	PRN
40	)	)	-RRB-	_	39	P
41	.	.	.	_	2	P

1	New	new	JJ	_	2	NMOD
2	loci	locus	NNS	_	0	ROOT
3	associated	associate	VBN	_	2	NMOD
4	with	with	IN	_	3	ADV
5	CIA	cia	NN	_	4	PMOD
6	in	in	IN	_	3	LOC
7	identified	identify	VBN	_	10	NMOD
8	old	old	JJ	_	10	NMOD
9	female	female	JJ	_	10	NMOD
10	mice	mouse	NNS	_	6	PMOD

1	The	the	DT	_	4	NMOD
2	genetic	genetic	JJ	_	4	NMOD
3	linkage	linkage	NN	_	4	NMOD
4	analysis	analysis	NN	_	5	SBJ
5	revealed	reveal	VBD	_	0	ROOT
6	one	one	CD	_	12	NMOD
7	significant	significant	JJ	_	12	NMOD
8	quantitative	quantitative	JJ	_	10	NMOD
9	trait	trait	NN	_	10	NMOD
10	locus	locus	NN	_	12	NMOD
11	(	(	-LRB-	_	12	P
12	QTL	qtl	NN	_	5	OBJ
13	)	)	-RRB-	_	12	P
14	located	locate	VBN	_	12	NMOD
15	at	at	IN	_	14	LOC
16	64	0	CD	_	19	NMOD
17	–	–	SYM	_	16	P
18	70	0	CD	_	16	QMOD
19	cM	cm	NN	_	15	PMOD
20	on	on	IN	_	14	LOC
21	chromosome	chromosome	NN	_	20	PMOD
22	11	0	CD	_	21	NMOD
23	(	(	-LRB-	_	24	P
24	Table	table	NN	_	5	PRN
25	3	0	CD	_	24	NMOD
26	and	and	CC	_	24	COORD
27	Figure	figure	NN	_	26	CONJ
28	2	0	CD	_	27	NMOD
29	)	)	-RRB-	_	24	P
30	.	.	.	_	5	P

1	This	this	DT	_	2	NMOD
2	locus	locus	NN	_	7	SBJ
3	(	(	-LRB-	_	2	P
4	denoted	denote	VBN	_	2	NMOD
5	Cia40	cia0	NN	_	4	OPRD
6	)	)	-RRB-	_	7	P
7	gave	give	VBD	_	0	ROOT
8	significant	significant	JJ	_	10	NMOD
9	LOD	lod	NN	_	10	NMOD
10	scores	score	NNS	_	7	OBJ
11	for	for	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	traits	trait	NNS	_	14	NMOD
14	incidence	incidence	NN	_	11	PMOD
15	(	(	-LRB-	_	18	P
16	LOD	lod	NN	_	18	SBJ
17	=	=	SYM	_	18	P
18	4.1	0	CD	_	14	PRN
19	)	)	-RRB-	_	18	P
20	and	and	CC	_	14	COORD
21	'	'	``	_	22	P
22	day	day	NN	_	20	CONJ
23	of	of	IN	_	22	NMOD
24	onset	onset	NN	_	23	PMOD
25	'	'	''	_	22	P
26	(	(	-LRB-	_	29	P
27	LOD	lod	NN	_	29	SBJ
28	=	=	SYM	_	29	P
29	4.0	0	CD	_	22	PRN
30	)	)	-RRB-	_	29	P
31	,	,	,	_	10	P
32	and	and	CC	_	10	COORD
33	a	a	DT	_	36	NMOD
34	suggestive	suggestive	JJ	_	36	NMOD
35	LOD	lod	NN	_	36	NMOD
36	score	score	NN	_	32	CONJ
37	for	for	IN	_	36	NMOD
38	the	the	DT	_	42	NMOD
39	trait	trait	NN	_	42	NMOD
40	'	'	``	_	42	P
41	arthritis	arthritis	NN	_	42	NMOD
42	score	score	NN	_	37	PMOD
43	'	'	''	_	36	P
44	(	(	-LRB-	_	47	P
45	LOD	lod	NN	_	47	SBJ
46	=	=	SYM	_	47	P
47	3.3	0	CD	_	36	PRN
48	)	)	-RRB-	_	47	P
49	.	.	.	_	7	P

1	Another	another	DT	_	2	NMOD
2	QTL	qtl	NN	_	11	SBJ
3	of	of	IN	_	2	NMOD
4	suggestive	suggestive	JJ	_	5	NMOD
5	significance	significance	NN	_	3	PMOD
6	for	for	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	incidence	incidence	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	disease	disease	NN	_	9	PMOD
11	was	be	VBD	_	0	ROOT
12	identified	identify	VBN	_	11	VC
13	around	around	IN	_	12	ADV
14	27	0	CD	_	15	NMOD
15	cM	cm	NN	_	13	PMOD
16	on	on	IN	_	12	LOC
17	chromosome	chromosome	NN	_	16	PMOD
18	1	0	CD	_	17	NMOD
19	(	(	-LRB-	_	20	P
20	Figure	figure	NN	_	12	PRN
21	2	0	CD	_	20	NMOD
22	)	)	-RRB-	_	20	P
23	.	.	.	_	11	P

1	Finally	finally	RB	_	12	ADV
2	,	,	,	_	12	P
3	a	a	DT	_	5	NMOD
4	suggestive	suggestive	JJ	_	5	NMOD
5	QTL	qtl	NN	_	12	SBJ
6	for	for	IN	_	5	NMOD
7	the	the	DT	_	8	NMOD
8	trait	trait	NN	_	11	NMOD
9	anti-CII	anti-cii	JJ	_	11	NMOD
10	antibody	antibody	NN	_	11	NMOD
11	titer	titer	NN	_	6	PMOD
12	was	be	VBD	_	0	ROOT
13	identified	identify	VBN	_	12	VC
14	on	on	IN	_	13	LOC
15	chromosome	chromosome	NN	_	14	PMOD
16	13	0	CD	_	15	NMOD
17	(	(	-LRB-	_	18	P
18	Figure	figure	NN	_	13	PRN
19	2	0	CD	_	18	NMOD
20	)	)	-RRB-	_	18	P
21	.	.	.	_	12	P

1	Discussion	discussion	NN	_	0	ROOT

1	Although	although	IN	_	18	ADV
2	carrying	carry	VBG	_	1	SUB
3	the	the	DT	_	9	NMOD
4	same	same	JJ	_	9	NMOD
5	CIA	cia	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	susceptible	susceptible	JJ	_	9	NMOD
8	MHC	mhc	NN	_	9	NMOD
9	region	region	NN	_	2	OBJ
10	,	,	,	_	18	P
11	the	the	DT	_	17	NMOD
12	NFR	nfr	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	N	n	NN	_	17	NMOD
15	and	and	CC	_	14	COORD
16	B10.Q	b0.q	NN	_	15	CONJ
17	mice	mouse	NNS	_	18	SBJ
18	are	be	VBP	_	0	ROOT
19	different	different	JJ	_	18	PRD
20	in	in	IN	_	18	MNR
21	several	several	JJ	_	22	NMOD
22	respects	respect	NNS	_	20	PMOD
23	.	.	.	_	18	P

1	The	the	DT	_	5	NMOD
2	NFR	nfr	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	N	n	NN	_	5	NMOD
5	mouse	mouse	NN	_	20	SBJ
6	,	,	,	_	5	P
7	which	which	WDT	_	8	SBJ
8	is	be	VBZ	_	5	NMOD
9	an	an	DT	_	12	NMOD
10	inbred	inbred	JJ	_	12	NMOD
11	NMRI	nmri	NN	_	12	NMOD
12	mouse	mouse	NN	_	8	PRD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	18	NMOD
15	H	h	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	2q	0q	NN	_	18	NMOD
18	haplotype	haplotype	NN	_	13	PMOD
19	,	,	,	_	20	P
20	is	be	VBZ	_	0	ROOT
21	larger	large	JJR	_	20	PRD
22	in	in	IN	_	21	AMOD
23	size	size	NN	_	22	PMOD
24	than	than	IN	_	21	AMOD
25	the	the	DT	_	27	NMOD
26	B10.Q	b0.q	NN	_	27	NMOD
27	mouse	mouse	NN	_	24	PMOD
28	and	and	CC	_	20	COORD
29	is	be	VBZ	_	28	CONJ
30	also	also	RB	_	29	ADV
31	known	know	VBN	_	29	VC
32	for	for	IN	_	31	ADV
33	its	its	PRP$	_	37	NMOD
34	extraordinarily	extraordinarily	RB	_	35	AMOD
35	good	good	JJ	_	37	NMOD
36	breeding	breeding	NN	_	37	NMOD
37	properties	property	NNS	_	32	PMOD
38	.	.	.	_	20	P

1	The	the	DT	_	2	NMOD
2	mice	mouse	NNS	_	21	SBJ
3	used	use	VBN	_	2	NMOD
4	in	in	IN	_	3	ADV
5	the	the	DT	_	7	NMOD
6	present	present	JJ	_	7	NMOD
7	study	study	NN	_	4	PMOD
8	,	,	,	_	2	P
9	(	(	-LRB-	_	17	P
10	NFR	nfr	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	N	n	NN	_	14	NMOD
13	×	×	SYM	_	14	P
14	B10.Q	b0.q	NN	_	17	NMOD
15	)	)	-RRB-	_	17	P
16	×	×	SYM	_	17	P
17	B10.Q	b0.q	NN	_	18	NMOD
18	females	female	NNS	_	2	APPO
19	,	,	,	_	21	P
20	first	$#ORD#$	RB	_	21	TMP
21	underwent	undergo	VBD	_	0	ROOT
22	a	a	DT	_	24	NMOD
23	genetic	genetic	JJ	_	24	NMOD
24	study	study	NN	_	21	OBJ
25	of	of	IN	_	24	NMOD
26	reproduction	reproduction	NN	_	25	PMOD
27	,	,	,	_	24	P
28	in	in	IN	_	39	ADV
29	which	which	WDT	_	28	PMOD
30	a	a	DT	_	31	NMOD
31	number	number	NN	_	38	SBJ
32	of	of	IN	_	31	NMOD
33	loci	locus	NNS	_	32	PMOD
34	associated	associate	VBN	_	33	NMOD
35	with	with	IN	_	34	ADV
36	breeding	breeding	NN	_	37	NMOD
37	performance	performance	NN	_	35	PMOD
38	were	be	VBD	_	24	NMOD
39	identified	identify	VBN	_	38	VC
40	(	(	-LRB-	_	41	P
41	Liljander	liljander	NNP	_	21	CIT
42	M	m	NNP	_	41	DEP
43	,	,	,	_	41	P
44	Sällström	sällström	NNP	_	41	DEP
45	MA	ma	NNP	_	41	DEP
46	,	,	,	_	41	P
47	Andersson	andersson	NNP	_	41	DEP
48	S	s	NNP	_	41	DEP
49	,	,	,	_	41	P
50	Wernhoff	wernhoff	NNP	_	41	DEP
51	P	p	NNP	_	41	DEP
52	,	,	,	_	41	P
53	Andersson	andersson	NNP	_	41	DEP
54	Å	å	NNP	_	41	DEP
55	,	,	,	_	41	P
56	Holmdahl	holmdahl	NNP	_	41	DEP
57	R	r	NNP	_	41	DEP
58	,	,	,	_	41	P
59	Mattsson	mattsson	NNP	_	41	DEP
60	R	r	NNP	_	41	DEP
61	;	;	:	_	41	P
62	unpublished	unpublished	JJ	_	41	DEP
63	data	datum	NNS	_	41	DEP
64	)	)	-RRB-	_	41	P
65	.	.	.	_	21	P

1	Since	since	IN	_	28	PRP
2	the	the	DT	_	4	NMOD
3	parental	parental	JJ	_	4	NMOD
4	strains	strain	NNS	_	5	SBJ
5	differ	differ	VBP	_	1	SUB
6	in	in	IN	_	5	ADV
7	susceptibility	susceptibility	NN	_	6	PMOD
8	to	to	IN	_	7	NMOD
9	CIA	cia	NN	_	8	PMOD
10	,	,	,	_	5	P
11	in	in	IN	_	5	ADV
12	spite	spite	NN	_	11	PMOD
13	of	of	IN	_	12	NMOD
14	both	both	DT	_	15	SBJ
15	having	have	VBG	_	13	PMOD
16	the	the	DT	_	22	NMOD
17	MHC	mhc	NN	_	22	NMOD
18	class	class	NN	_	20	NMOD
19	II	ii	CD	_	20	NMOD
20	A	a	NN	_	22	NMOD
21	beta	beta	NN	_	22	NMOD
22	genes	gene	NNS	_	15	OBJ
23	[	[	-LRB-	_	24	P
24	15	0	CD	_	15	PRN
25	]	]	-RRB-	_	24	P
26	,	,	,	_	28	P
27	we	we	PRP	_	28	SBJ
28	wanted	want	VBD	_	0	ROOT
29	to	to	TO	_	28	OPRD
30	test	test	VB	_	29	IM
31	the	the	DT	_	32	NMOD
32	susceptibility	susceptibility	NN	_	30	OBJ
33	to	to	IN	_	32	NMOD
34	inflammatory	inflammatory	JJ	_	35	NMOD
35	disease	disease	NN	_	33	PMOD
36	in	in	IN	_	30	LOC
37	mice	mouse	NNS	_	36	PMOD
38	from	from	IN	_	37	NMOD
39	this	this	DT	_	40	NMOD
40	cross	cross	NN	_	38	PMOD
41	.	.	.	_	28	P

1	In	in	IN	_	6	ADV
2	fact	fact	NN	_	1	PMOD
3	,	,	,	_	6	P
4	this	this	DT	_	5	NMOD
5	situation	situation	NN	_	6	SBJ
6	gave	give	VBD	_	0	ROOT
7	an	an	DT	_	8	NMOD
8	opportunity	opportunity	NN	_	6	OBJ
9	to	to	TO	_	8	NMOD
10	study	study	VB	_	9	IM
11	the	the	DT	_	13	NMOD
12	genetic	genetic	JJ	_	13	NMOD
13	control	control	NN	_	10	OBJ
14	of	of	IN	_	13	NMOD
15	arthritis	arthritis	NN	_	14	PMOD
16	in	in	IN	_	10	LOC
17	aged	aged	JJ	_	19	NMOD
18	multiparous	multiparous	JJ	_	19	NMOD
19	females	female	NNS	_	16	PMOD
20	,	,	,	_	19	P
21	a	a	DT	_	23	NMOD
22	common	common	JJ	_	23	NMOD
23	situation	situation	NN	_	19	APPO
24	in	in	IN	_	23	NMOD
25	human	human	JJ	_	26	NMOD
26	RA	ra	NN	_	24	PMOD
27	.	.	.	_	6	P

1	This	this	DT	_	2	NMOD
2	susceptibility	susceptibility	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	important	important	JJ	_	3	PRD
5	to	to	TO	_	4	AMOD
6	investigate	investigate	VB	_	5	IM
7	for	for	IN	_	3	PRP
8	various	various	JJ	_	9	NMOD
9	reasons	reason	NNS	_	7	PMOD
10	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	fact	fact	NN	_	11	SBJ
3	that	that	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	differed	differ	VBD	_	3	SUB
7	in	in	IN	_	6	ADV
8	their	their	PRP$	_	10	NMOD
9	reproductive	reproductive	JJ	_	10	NMOD
10	history	history	NN	_	7	PMOD
11	made	make	VBD	_	0	ROOT
12	it	it	PRP	_	11	OBJ
13	possible	possible	JJ	_	12	OPRD
14	to	to	TO	_	12	DEP
15	analyze	analyze	VB	_	14	IM
16	whether	whether	IN	_	15	OBJ
17	this	this	DT	_	18	SBJ
18	would	would	MD	_	16	SUB
19	significantly	significantly	RB	_	18	ADV
20	affect	affect	VB	_	18	VC
21	the	the	DT	_	22	NMOD
22	incidence	incidence	NN	_	20	OBJ
23	or	or	CC	_	22	COORD
24	severity	severity	NN	_	23	CONJ
25	of	of	IN	_	22	NMOD
26	CIA	cia	NN	_	25	PMOD
27	.	.	.	_	11	P

1	Second	$#ORD#$	RB	_	18	ADV
2	,	,	,	_	18	P
3	almost	almost	RB	_	7	NMOD
4	all	all	PDT	_	7	NMOD
5	the	the	DT	_	7	NMOD
6	linkage	linkage	NN	_	7	NMOD
7	analyses	analysis	NNS	_	18	SBJ
8	performed	perform	VBN	_	7	NMOD
9	for	for	IN	_	8	PRP
10	detection	detection	NN	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	CIA	cia	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	associated	associate	VBN	_	15	NMOD
15	loci	locus	NNS	_	11	PMOD
16	in	in	IN	_	10	LOC
17	mice	mouse	NNS	_	16	PMOD
18	have	have	VBP	_	0	ROOT
19	been	be	VBN	_	18	VC
20	carried	carry	VBN	_	19	VC
21	out	out	RP	_	20	PRT
22	with	with	IN	_	20	MNR
23	male	male	JJ	_	24	NMOD
24	mice	mouse	NNS	_	22	PMOD
25	.	.	.	_	18	P

1	Another	another	DT	_	2	NMOD
2	reason	reason	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	that	that	IN	_	3	PRD
5	the	the	DT	_	6	NMOD
6	use	use	NN	_	11	SBJ
7	of	of	IN	_	6	NMOD
8	old	old	JJ	_	10	NMOD
9	multiparous	multiparous	JJ	_	10	NMOD
10	mice	mouse	NNS	_	7	PMOD
11	mimicked	mimic	VBD	_	4	SUB
12	the	the	DT	_	14	NMOD
13	RA	ra	NN	_	14	NMOD
14	situation	situation	NN	_	11	OBJ
15	(	(	-LRB-	_	18	P
16	older	old	JJR	_	17	NMOD
17	women	woman	NNS	_	18	SBJ
18	is	be	VBZ	_	11	PRN
19	the	the	DT	_	22	NMOD
20	major	major	JJ	_	21	NMOD
21	risk	risk	NN	_	22	NMOD
22	group	group	NN	_	18	PRD
23	)	)	-RRB-	_	18	P
24	.	.	.	_	3	P

1	Finally	finally	RB	_	8	ADV
2	,	,	,	_	8	P
3	the	the	DT	_	7	NMOD
4	NFR	nfr	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	N	n	NN	_	7	NMOD
7	strain	strain	NN	_	8	SBJ
8	had	have	VBD	_	0	ROOT
9	not	not	RB	_	8	ADV
10	previously	previously	RB	_	8	TMP
11	been	be	VBN	_	8	VC
12	used	use	VBN	_	11	VC
13	in	in	IN	_	12	ADV
14	linkage	linkage	NN	_	15	NMOD
15	analyses	analysis	NNS	_	13	PMOD
16	for	for	IN	_	12	PRP
17	detection	detection	NN	_	16	PMOD
18	of	of	IN	_	17	NMOD
19	CIA	cia	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	associated	associate	VBN	_	22	NMOD
22	loci	locus	NNS	_	18	PMOD
23	,	,	,	_	12	P
24	which	which	WDT	_	25	SBJ
25	opened	open	VBN	_	12	ADV
26	(	(	-LRB-	_	25	P
27	up	up	RP	_	25	PRT
28	)	)	-RRB-	_	25	P
29	the	the	DT	_	30	NMOD
30	possibility	possibility	NN	_	25	OBJ
31	of	of	IN	_	30	NMOD
32	detecting	detect	VBG	_	31	PMOD
33	new	new	JJ	_	35	NMOD
34	polymorphic	polymorphic	JJ	_	35	NMOD
35	genes	gene	NNS	_	32	OBJ
36	of	of	IN	_	35	NMOD
37	importance	importance	NN	_	36	PMOD
38	in	in	IN	_	32	ADV
39	this	this	DT	_	40	NMOD
40	disease	disease	NN	_	38	PMOD
41	.	.	.	_	8	P

1	The	the	DT	_	3	NMOD
2	first	$#ORD#$	JJ	_	3	NMOD
3	conclusion	conclusion	NN	_	8	SBJ
4	from	from	IN	_	3	NMOD
5	the	the	DT	_	7	NMOD
6	present	present	JJ	_	7	NMOD
7	paper	paper	NN	_	4	PMOD
8	is	be	VBZ	_	0	ROOT
9	that	that	IN	_	8	PRD
10	multiparity	multiparity	NN	_	11	SBJ
11	does	do	VBZ	_	9	SUB
12	not	not	RB	_	11	ADV
13	negatively	negatively	RB	_	11	ADV
14	influence	influence	VB	_	11	VC
15	the	the	DT	_	16	NMOD
16	incidence	incidence	NN	_	14	OBJ
17	or	or	CC	_	16	COORD
18	severity	severity	NN	_	17	CONJ
19	of	of	IN	_	16	NMOD
20	CIA	cia	NN	_	19	PMOD
21	induced	induce	VBN	_	20	NMOD
22	later	later	RB	_	21	TMP
23	in	in	IN	_	22	AMOD
24	life	life	NN	_	23	PMOD
25	(	(	-LRB-	_	26	P
26	Table	table	NN	_	14	PRN
27	2	0	CD	_	26	NMOD
28	)	)	-RRB-	_	26	P
29	.	.	.	_	8	P

1	This	this	DT	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	in	in	IN	_	2	PRD
4	agreement	agreement	NN	_	3	PMOD
5	with	with	IN	_	4	NMOD
6	results	result	NNS	_	5	PMOD
7	from	from	IN	_	6	NMOD
8	a	a	DT	_	10	NMOD
9	recent	recent	JJ	_	10	NMOD
10	study	study	NN	_	7	PMOD
11	of	of	IN	_	10	NMOD
12	RA	ra	NN	_	11	PMOD
13	in	in	IN	_	12	LOC
14	women	woman	NNS	_	13	PMOD
15	,	,	,	_	10	P
16	which	which	WDT	_	18	SBJ
17	similarly	similarly	RB	_	18	ADV
18	indicates	indicate	VBZ	_	10	NMOD
19	that	that	IN	_	18	OBJ
20	previous	previous	JJ	_	21	NMOD
21	experience	experience	NN	_	24	SBJ
22	of	of	IN	_	21	NMOD
23	pregnancy	pregnancy	NN	_	22	PMOD
24	does	do	VBZ	_	19	SUB
25	not	not	RB	_	24	ADV
26	negatively	negatively	RB	_	24	ADV
27	affect	affect	VB	_	24	VC
28	the	the	DT	_	29	NMOD
29	incidence	incidence	NN	_	27	OBJ
30	or	or	CC	_	29	COORD
31	severity	severity	NN	_	30	CONJ
32	of	of	IN	_	29	NMOD
33	RA	ra	NN	_	32	PMOD
34	later	later	RB	_	27	TMP
35	in	in	IN	_	34	AMOD
36	life	life	NN	_	35	PMOD
37	[	[	-LRB-	_	38	P
38	8	0	CD	_	2	PRN
39	]	]	-RRB-	_	38	P
40	.	.	.	_	2	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	worth	worth	JJ	_	2	PRD
4	noting	note	VBG	_	3	AMOD
5	that	that	IN	_	2	OBJ
6	the	the	DT	_	7	NMOD
7	situation	situation	NN	_	8	SBJ
8	is	be	VBZ	_	5	SUB
9	quite	quite	RB	_	10	AMOD
10	different	different	JJ	_	8	PRD
11	if	if	IN	_	8	ADV
12	pregnancy	pregnancy	NN	_	13	SBJ
13	is	be	VBZ	_	11	SUB
14	entered	enter	VBN	_	13	VC
15	during	during	IN	_	14	TMP
16	ongoing	ongoing	JJ	_	17	NMOD
17	arthritis	arthritis	NN	_	15	PMOD
18	.	.	.	_	2	P

1	This	this	DT	_	2	SBJ
2	will	will	MD	_	0	ROOT
3	normally	normally	RB	_	2	ADV
4	lead	lead	VB	_	2	VC
5	to	to	IN	_	4	ADV
6	a	a	DT	_	8	NMOD
7	temporary	temporary	JJ	_	8	NMOD
8	remission	remission	NN	_	5	PMOD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	11	NMOD
11	disease	disease	NN	_	9	PMOD
12	in	in	IN	_	8	LOC
13	both	both	CC	_	14	COORD
14	mice	mouse	NNS	_	12	PMOD
15	and	and	CC	_	14	COORD
16	humans	human	NNS	_	15	CONJ
17	,	,	,	_	8	P
18	followed	follow	VBN	_	8	NMOD
19	by	by	IN	_	18	LGS
20	an	an	DT	_	22	NMOD
21	exacerbation	exacerbation	NN	_	22	NMOD
22	phase	phase	NN	_	19	PMOD
23	after	after	IN	_	22	TMP
24	delivery	delivery	NN	_	23	PMOD
25	[	[	-LRB-	_	30	P
26	7	0	CD	_	30	NMOD
27	,	,	,	_	30	P
28	10	0	CD	_	30	NMOD
29	,	,	,	_	30	P
30	11	0	CD	_	4	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	second	$#ORD#$	JJ	_	3	NMOD
3	conclusion	conclusion	NN	_	7	SBJ
4	from	from	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	study	study	NN	_	4	PMOD
7	is	be	VBZ	_	0	ROOT
8	that	that	IN	_	7	PRD
9	loci	locus	NNS	_	15	SBJ
10	of	of	IN	_	9	NMOD
11	possible	possible	JJ	_	12	NMOD
12	importance	importance	NN	_	10	PMOD
13	for	for	IN	_	12	NMOD
14	CIA	cia	NN	_	13	PMOD
15	have	have	VBP	_	8	SUB
16	been	be	VBN	_	15	VC
17	detected	detect	VBN	_	16	VC
18	,	,	,	_	17	P
19	two	two	CD	_	26	NMOD
20	associated	associate	VBN	_	19	NMOD
21	with	with	IN	_	20	ADV
22	arthritis	arthritis	NN	_	23	NMOD
23	susceptibility	susceptibility	NN	_	21	PMOD
24	(	(	-LRB-	_	26	P
25	chromosomes	chromosome	NNS	_	26	NMOD
26	1	0	CD	_	9	NMOD
27	and	and	CC	_	26	COORD
28	11	0	CD	_	27	CONJ
29	)	)	-RRB-	_	26	P
30	and	and	CC	_	26	COORD
31	one	one	CD	_	37	NMOD
32	associated	associate	VBN	_	31	NMOD
33	with	with	IN	_	32	ADV
34	anti-CII	anti-cii	JJ	_	35	NMOD
35	titers	titer	NNS	_	33	PMOD
36	(	(	-LRB-	_	37	P
37	chromosome	chromosome	NN	_	30	CONJ
38	13	0	CD	_	37	NMOD
39	)	)	-RRB-	_	7	P
40	.	.	.	_	7	P

1	Some	some	DT	_	3	NMOD
2	arthritis	arthritis	NN	_	3	NMOD
3	loci	locus	NNS	_	4	SBJ
4	have	have	VBP	_	12	DEP
5	previously	previously	RB	_	4	TMP
6	been	be	VBN	_	4	VC
7	identified	identify	VBN	_	6	VC
8	on	on	IN	_	7	LOC
9	chromosome	chromosome	NN	_	8	PMOD
10	1	0	CD	_	9	NMOD
11	:	:	:	_	12	P
12	Cia15	cia0	NN	_	0	ROOT
13	at	at	IN	_	12	LOC
14	8	0	CD	_	15	NMOD
15	cM	cm	NN	_	13	PMOD
16	[	[	-LRB-	_	17	P
17	16	0	CD	_	12	PRN
18	]	]	-RRB-	_	17	P
19	,	,	,	_	12	P
20	Cia20	cia0	NN	_	12	CONJ
21	at	at	IN	_	20	LOC
22	44	0	CD	_	23	NMOD
23	cM	cm	NN	_	21	PMOD
24	[	[	-LRB-	_	25	P
25	16	0	CD	_	20	PRN
26	]	]	-RRB-	_	25	P
27	and	and	CC	_	20	COORD
28	Cia9	cia0	NN	_	27	CONJ
29	at	at	IN	_	28	LOC
30	92	0	CD	_	31	NMOD
31	cM	cm	NN	_	29	PMOD
32	[	[	-LRB-	_	33	P
33	17	0	CD	_	28	PRN
34	]	]	-RRB-	_	33	P
35	.	.	.	_	12	P

1	However	however	RB	_	7	ADV
2	,	,	,	_	7	P
3	none	none	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	these	these	DT	_	6	NMOD
6	loci	locus	NNS	_	4	PMOD
7	appears	appear	VBZ	_	0	ROOT
8	to	to	TO	_	7	OPRD
9	be	be	VB	_	8	IM
10	close	close	RB	_	9	PRD
11	to	to	IN	_	10	AMOD
12	the	the	DT	_	13	NMOD
13	locus	locus	NN	_	11	PMOD
14	found	find	VBN	_	13	NMOD
15	on	on	IN	_	14	LOC
16	chromosome	chromosome	NN	_	15	PMOD
17	1	0	CD	_	16	NMOD
18	in	in	IN	_	14	ADV
19	the	the	DT	_	21	NMOD
20	present	present	JJ	_	21	NMOD
21	study	study	NN	_	18	PMOD
22	.	.	.	_	7	P

1	The	the	DT	_	5	NMOD
2	newly	newly	RB	_	3	AMOD
3	identified	identify	VBN	_	5	NMOD
4	Cia40	cia0	NN	_	5	NMOD
5	locus	locus	NN	_	6	SBJ
6	includes	include	VBZ	_	0	ROOT
7	the	the	DT	_	12	NMOD
8	Ctla4	ctla0	NN	_	12	NMOD
9	(	(	-LRB-	_	10	P
10	CD152	cd0	NN	_	8	PRN
11	)	)	-RRB-	_	10	P
12	gene	gene	NN	_	6	OBJ
13	,	,	,	_	12	P
14	which	which	WDT	_	15	SBJ
15	is	be	VBZ	_	12	NMOD
16	a	a	DT	_	18	NMOD
17	strong	strong	JJ	_	18	NMOD
18	candidate	candidate	NN	_	15	PRD
19	associated	associate	VBN	_	18	NMOD
20	with	with	IN	_	19	ADV
21	spontaneous	spontaneous	JJ	_	22	NMOD
22	diabetes	diabetes	NN	_	20	PMOD
23	identified	identify	VBN	_	18	NMOD
24	in	in	IN	_	23	ADV
25	crosses	crosse	NNS	_	24	PMOD
26	between	between	IN	_	25	NMOD
27	C57Bl	c0bl	NN	_	26	PMOD
28	and	and	CC	_	27	COORD
29	nonobese	nonobese	JJ	_	31	NMOD
30	diabetic	diabetic	JJ	_	31	NMOD
31	strains	strain	NNS	_	28	CONJ
32	[	[	-LRB-	_	33	P
33	18	0	CD	_	6	PRN
34	]	]	-RRB-	_	33	P
35	.	.	.	_	6	P

1	Analyses	analysis	NNS	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	CIA	cia	NN	_	2	PMOD
4	in	in	IN	_	1	LOC
5	crosses	crosse	NNS	_	4	PMOD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	same	same	JJ	_	9	NMOD
9	backgrounds	background	NNS	_	6	PMOD
10	,	,	,	_	13	P
11	however	however	RB	_	13	ADV
12	,	,	,	_	13	P
13	did	do	VBD	_	0	ROOT
14	not	not	RB	_	13	ADV
15	identify	identify	VB	_	13	VC
16	a	a	DT	_	17	NMOD
17	linkage	linkage	NN	_	15	OBJ
18	to	to	IN	_	17	NMOD
19	this	this	DT	_	20	NMOD
20	locus	locus	NN	_	18	PMOD
21	,	,	,	_	15	P
22	suggesting	suggest	VBG	_	15	ADV
23	that	that	IN	_	22	OBJ
24	the	the	DT	_	25	NMOD
25	polymorphism	polymorphism	NN	_	28	SBJ
26	underlying	underlie	VBG	_	25	NMOD
27	Cia40	cia0	NN	_	26	OBJ
28	differs	differ	VBZ	_	23	SUB
29	from	from	IN	_	28	ADV
30	the	the	DT	_	31	NMOD
31	genes	gene	NNS	_	29	PMOD
32	associated	associate	VBN	_	31	NMOD
33	with	with	IN	_	32	ADV
34	diabetes	diabetes	NN	_	33	PMOD
35	[	[	-LRB-	_	36	P
36	18	0	CD	_	15	PRN
37	]	]	-RRB-	_	36	P
38	.	.	.	_	13	P

1	Interestingly	interestingly	RB	_	7	ADV
2	,	,	,	_	7	P
3	Bauer	bauer	NNP	_	7	SBJ
4	and	and	CC	_	3	COORD
5	colleagues	colleague	NNS	_	4	CONJ
6	previously	previously	RB	_	7	TMP
7	identified	identify	VBD	_	0	ROOT
8	a	a	DT	_	9	NMOD
9	locus	locus	NN	_	7	OBJ
10	(	(	-LRB-	_	11	P
11	Cia28	cia0	NN	_	9	PRN
12	)	)	-RRB-	_	11	P
13	associated	associate	VBN	_	9	NMOD
14	with	with	IN	_	13	ADV
15	anti-CII	anti-cii	JJ	_	17	NMOD
16	antibody	antibody	NN	_	17	NMOD
17	production	production	NN	_	14	PMOD
18	at	at	IN	_	7	LOC
19	53	0	CD	_	20	NMOD
20	cM	cm	NN	_	18	PMOD
21	on	on	IN	_	20	LOC
22	chromosome	chromosome	NN	_	21	PMOD
23	13	0	CD	_	22	NMOD
24	[	[	-LRB-	_	25	P
25	19	0	CD	_	22	PRN
26	]	]	-RRB-	_	25	P
27	,	,	,	_	20	P
28	which	which	WDT	_	29	SBJ
29	is	be	VBZ	_	20	NMOD
30	approximately	approximately	RB	_	31	PMOD
31	at	at	IN	_	29	LOC
32	the	the	DT	_	34	NMOD
33	same	same	JJ	_	34	NMOD
34	position	position	NN	_	31	PMOD
35	as	as	IN	_	34	NMOD
36	where	where	WRB	_	38	LOC
37	we	we	PRP	_	38	SBJ
38	find	find	VBP	_	35	PMOD
39	the	the	DT	_	40	NMOD
40	linkage	linkage	NN	_	38	OBJ
41	for	for	IN	_	40	NMOD
42	this	this	DT	_	43	NMOD
43	trait	trait	NN	_	41	PMOD
44	in	in	IN	_	38	ADV
45	the	the	DT	_	47	NMOD
46	present	present	JJ	_	47	NMOD
47	study	study	NN	_	44	PMOD
48	.	.	.	_	7	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	therefore	therefore	RB	_	2	ADV
4	most	most	RBS	_	5	AMOD
5	likely	likely	JJ	_	2	PRD
6	that	that	IN	_	2	OBJ
7	the	the	DT	_	8	NMOD
8	QTL	qtl	NN	_	15	SBJ
9	we	we	PRP	_	10	SBJ
10	have	have	VBP	_	8	NMOD
11	identified	identify	VBN	_	10	VC
12	on	on	IN	_	11	LOC
13	chromosome	chromosome	NN	_	12	PMOD
14	13	0	CD	_	13	NMOD
15	is	be	VBZ	_	6	SUB
16	the	the	DT	_	17	NMOD
17	same	same	JJ	_	15	PRD
18	as	as	IN	_	17	NMOD
19	Cia28	cia0	NN	_	18	PMOD
20	.	.	.	_	2	P

1	Since	since	IN	_	30	PRP
2	the	the	DT	_	5	NMOD
3	possible	possible	JJ	_	5	NMOD
4	new	new	JJ	_	5	NMOD
5	locus	locus	NN	_	12	SBJ
6	of	of	IN	_	5	NMOD
7	potential	potential	JJ	_	8	NMOD
8	interest	interest	NN	_	6	PMOD
9	on	on	IN	_	5	LOC
10	chromosome	chromosome	NN	_	9	PMOD
11	1	0	CD	_	10	NMOD
12	was	be	VBD	_	1	SUB
13	of	of	IN	_	12	PRD
14	suggestive	suggestive	JJ	_	15	NMOD
15	significance	significance	NN	_	13	PMOD
16	,	,	,	_	1	P
17	and	and	CC	_	1	COORD
18	since	since	IN	_	17	CONJ
19	the	the	DT	_	20	NMOD
20	locus	locus	NN	_	26	SBJ
21	identified	identify	VBN	_	20	NMOD
22	on	on	IN	_	21	LOC
23	chromosome	chromosome	NN	_	22	PMOD
24	13	0	CD	_	23	NMOD
25	probably	probably	RB	_	26	ADV
26	is	be	VBZ	_	18	SUB
27	Cia28	cia0	NN	_	26	PRD
28	,	,	,	_	30	P
29	we	we	PRP	_	30	SBJ
30	are	be	VBP	_	0	ROOT
31	now	now	RB	_	30	TMP
32	paying	pay	VBG	_	30	VC
33	special	special	JJ	_	34	NMOD
34	attention	attention	NN	_	32	OBJ
35	to	to	IN	_	32	ADV
36	the	the	DT	_	38	NMOD
37	significant	significant	JJ	_	38	NMOD
38	QTL	qtl	NN	_	35	PMOD
39	for	for	IN	_	38	NMOD
40	CIA	cia	NN	_	41	NMOD
41	incidence	incidence	NN	_	39	PMOD
42	detected	detect	VBN	_	38	NMOD
43	at	at	IN	_	42	LOC
44	60	0	CD	_	47	NMOD
45	–	–	SYM	_	44	P
46	70	0	CD	_	44	QMOD
47	cM	cm	NN	_	43	PMOD
48	on	on	IN	_	47	LOC
49	chromosome	chromosome	NN	_	48	PMOD
50	11	0	CD	_	49	NMOD
51	(	(	-LRB-	_	52	P
52	denoted	denote	VBN	_	42	PRN
53	Cia40	cia0	NN	_	52	OPRD
54	)	)	-RRB-	_	52	P
55	.	.	.	_	30	P

1	No	no	DT	_	4	NMOD
2	other	other	JJ	_	4	NMOD
3	CIA	cia	NN	_	4	NMOD
4	genes	gene	NNS	_	5	SBJ
5	have	have	VBP	_	0	ROOT
6	previously	previously	RB	_	5	TMP
7	been	be	VBN	_	5	VC
8	typed	type	VBN	_	7	VC
9	in	in	IN	_	8	LOC
10	this	this	DT	_	11	NMOD
11	region	region	NN	_	9	PMOD
12	,	,	,	_	5	P
13	but	but	CC	_	5	COORD
14	the	the	DT	_	16	NMOD
15	central	central	JJ	_	16	NMOD
16	part	part	NN	_	20	SBJ
17	of	of	IN	_	16	NMOD
18	chromosome	chromosome	NN	_	17	PMOD
19	11	0	CD	_	18	NMOD
20	is	be	VBZ	_	13	CONJ
21	known	know	VBN	_	20	VC
22	to	to	TO	_	21	OPRD
23	contain	contain	VB	_	22	IM
24	a	a	DT	_	25	NMOD
25	number	number	NN	_	23	OBJ
26	of	of	IN	_	25	NMOD
27	inflammation	inflammation	NN	_	28	NMOD
28	loci	locus	NNS	_	26	PMOD
29	,	,	,	_	28	P
30	such	such	JJ	_	31	PMOD
31	as	as	IN	_	28	NMOD
32	Eae22	eae0	NN	_	31	PMOD
33	,	,	,	_	32	P
34	Eae6b	eae0b	NN	_	32	CONJ
35	,	,	,	_	34	P
36	Eae23	eae0	NN	_	34	CONJ
37	and	and	CC	_	36	COORD
38	Eae7	eae0	NN	_	37	CONJ
39	[	[	-LRB-	_	40	P
40	20	0	CD	_	21	PRN
41	-	-	SYM	_	42	P
42	22	0	CD	_	40	NMOD
43	]	]	-RRB-	_	40	P
44	.	.	.	_	5	P

1	One	one	CD	_	2	NMOD
2	QTL	qtl	NN	_	17	SBJ
3	for	for	IN	_	2	NMOD
4	proteoglycan	proteoglycan	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	induced	induce	VBN	_	7	NMOD
7	arthritis	arthritis	NN	_	3	PMOD
8	,	,	,	_	7	P
9	which	which	WDT	_	10	SBJ
10	was	be	VBD	_	7	NMOD
11	female	female	JJ	_	12	AMOD
12	specific	specific	JJ	_	10	PRD
13	for	for	IN	_	12	AMOD
14	disease	disease	NN	_	15	NMOD
15	onset	onset	NN	_	13	PMOD
16	,	,	,	_	17	P
17	have	have	VBP	_	0	ROOT
18	also	also	RB	_	17	ADV
19	been	be	VBN	_	17	VC
20	found	find	VBN	_	19	VC
21	on	on	IN	_	20	LOC
22	chromosome	chromosome	NN	_	21	PMOD
23	11	0	CD	_	22	NMOD
24	.	.	.	_	17	P

1	Although	although	IN	_	17	ADV
2	this	this	DT	_	3	NMOD
3	locus	locus	NN	_	7	SBJ
4	(	(	-LRB-	_	5	P
5	Pgia28	pgia0	NN	_	3	PRN
6	)	)	-RRB-	_	5	P
7	is	be	VBZ	_	1	SUB
8	not	not	RB	_	7	ADV
9	located	locate	VBN	_	7	VC
10	in	in	IN	_	9	LOC
11	the	the	DT	_	12	NMOD
12	vicinity	vicinity	NN	_	10	PMOD
13	of	of	IN	_	12	NMOD
14	Cia40	cia0	NN	_	13	PMOD
15	,	,	,	_	17	P
16	it	it	PRP	_	17	SBJ
17	is	be	VBZ	_	0	ROOT
18	worth	worth	JJ	_	17	PRD
19	noting	note	VBG	_	18	AMOD
20	[	[	-LRB-	_	21	P
21	23	0	CD	_	17	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	17	P

1	The	the	DT	_	3	NMOD
2	mouse	mouse	NN	_	3	NMOD
3	chromosome	chromosome	NN	_	5	SBJ
4	11	0	CD	_	3	NMOD
5	contains	contain	VBZ	_	0	ROOT
6	several	several	JJ	_	7	NMOD
7	genes	gene	NNS	_	5	OBJ
8	that	that	WDT	_	9	SBJ
9	are	be	VBP	_	7	NMOD
10	highly	highly	RB	_	11	AMOD
11	conserved	conserved	JJ	_	9	PRD
12	with	with	IN	_	11	AMOD
13	human	human	JJ	_	14	NMOD
14	chromosome	chromosome	NN	_	12	PMOD
15	17	0	CD	_	14	NMOD
16	.	.	.	_	5	P

1	Linkages	linkage	NNS	_	5	SBJ
2	for	for	IN	_	1	NMOD
3	human	human	JJ	_	4	NMOD
4	RA	ra	NN	_	2	PMOD
5	have	have	VBP	_	0	ROOT
6	been	be	VBN	_	5	VC
7	found	find	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	this	this	DT	_	11	NMOD
10	particular	particular	JJ	_	11	NMOD
11	region	region	NN	_	8	PMOD
12	[	[	-LRB-	_	13	P
13	24	0	CD	_	7	PRN
14	]	]	-RRB-	_	13	P
15	.	.	.	_	5	P

1	Another	another	DT	_	3	NMOD
2	interesting	interesting	JJ	_	3	NMOD
3	locus	locus	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	Cia5	cia0	NN	_	4	PRD
6	on	on	IN	_	4	LOC
7	the	the	DT	_	8	NMOD
8	homolog	homolog	NN	_	10	NMOD
9	rat	rat	NN	_	10	NMOD
10	chromosome	chromosome	NN	_	6	PMOD
11	10	0	CD	_	10	NMOD
12	,	,	,	_	10	P
13	which	which	WDT	_	14	SBJ
14	regulates	regulate	VBZ	_	10	NMOD
15	the	the	DT	_	16	NMOD
16	severity	severity	NN	_	14	OBJ
17	of	of	IN	_	16	NMOD
18	CIA	cia	NN	_	17	PMOD
19	and	and	CC	_	18	COORD
20	pristane	pristane	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	induced	induce	VBN	_	23	NMOD
23	arthritis	arthritis	NN	_	19	CONJ
24	[	[	-LRB-	_	25	P
25	25	0	CD	_	4	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	4	P

1	Interestingly	interestingly	RB	_	11	ADV
2	,	,	,	_	11	P
3	from	from	IN	_	11	ADV
4	studies	study	NNS	_	3	PMOD
5	with	with	IN	_	4	NMOD
6	the	the	DT	_	8	NMOD
7	same	same	JJ	_	8	NMOD
8	cross	cross	NN	_	5	PMOD
9	,	,	,	_	11	P
10	we	we	PRP	_	11	SBJ
11	have	have	VBP	_	0	ROOT
12	previously	previously	RB	_	11	TMP
13	detected	detect	VBN	_	11	VC
14	a	a	DT	_	16	NMOD
15	significant	significant	JJ	_	16	NMOD
16	QTL	qtl	NN	_	13	OBJ
17	denoted	denote	VBN	_	16	NMOD
18	Pregq2	pregq0	NN	_	17	OPRD
19	for	for	IN	_	16	NMOD
20	the	the	DT	_	21	NMOD
21	trait	trait	NN	_	24	NMOD
22	'	'	``	_	24	P
23	pregnancy	pregnancy	NN	_	24	NMOD
24	frequency	frequency	NN	_	19	PMOD
25	'	'	''	_	13	P
26	in	in	IN	_	13	LOC
27	the	the	DT	_	30	NMOD
28	very	very	RB	_	29	AMOD
29	same	same	JJ	_	30	NMOD
30	region	region	NN	_	26	PMOD
31	as	as	IN	_	30	NMOD
32	Cia40	cia0	NN	_	31	PMOD
33	(	(	-LRB-	_	34	P
34	peak	peak	NN	_	13	PRN
35	at	at	IN	_	34	LOC
36	64	0	CD	_	39	NMOD
37	–	–	SYM	_	36	P
38	70	0	CD	_	36	QMOD
39	cM	cm	NN	_	35	PMOD
40	on	on	IN	_	39	NMOD
41	chromosome	chromosome	NN	_	40	PMOD
42	11	0	CD	_	41	NMOD
43	)	)	-RRB-	_	34	P
44	(	(	-LRB-	_	45	P
45	Liljander	liljander	NNP	_	13	CIT
46	M	m	NNP	_	45	DEP
47	,	,	,	_	45	P
48	Sällström	sällström	NNP	_	45	DEP
49	MA	ma	NNP	_	45	DEP
50	,	,	,	_	45	P
51	Andersson	andersson	NNP	_	45	DEP
52	S	s	NNP	_	45	DEP
53	,	,	,	_	45	P
54	Wernhoff	wernhoff	NNP	_	45	DEP
55	P	p	NNP	_	45	DEP
56	,	,	,	_	45	P
57	Andersson	andersson	NNP	_	45	DEP
58	Å	å	NNP	_	45	DEP
59	,	,	,	_	45	P
60	Holmdahl	holmdahl	NNP	_	45	DEP
61	R	r	NNP	_	45	DEP
62	,	,	,	_	45	P
63	Mattsson	mattsson	NNP	_	45	DEP
64	R	r	NNP	_	45	DEP
65	,	,	,	_	45	P
66	unpublished	unpublished	JJ	_	45	DEP
67	data	datum	NNS	_	45	DEP
68	)	)	-RRB-	_	45	P
69	.	.	.	_	11	P

1	This	this	DT	_	2	SBJ
2	means	mean	VBZ	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	this	this	DT	_	5	NMOD
5	region	region	NN	_	6	SBJ
6	contains	contain	VBZ	_	3	SUB
7	genes	gene	NNS	_	6	OBJ
8	affecting	affect	VBG	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	CIA	cia	NN	_	11	NMOD
11	incidence	incidence	NN	_	8	OBJ
12	in	in	IN	_	11	LOC
13	multiparous	multiparous	JJ	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	in	in	IN	_	8	ADV
16	addition	addition	NN	_	15	PMOD
17	to	to	IN	_	16	NMOD
18	the	the	DT	_	19	NMOD
19	rate	rate	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	successful	successful	JJ	_	22	NMOD
22	deliveries	delivery	NNS	_	20	PMOD
23	in	in	IN	_	19	LOC
24	female	female	JJ	_	25	NMOD
25	mice	mouse	NNS	_	23	PMOD
26	.	.	.	_	2	P

1	The	the	DT	_	4	NMOD
2	'	'	``	_	4	P
3	pregnancy	pregnancy	NN	_	4	NMOD
4	rate	rate	NN	_	8	SBJ
5	'	'	''	_	4	P
6	in	in	IN	_	4	LOC
7	mice	mouse	NNS	_	6	PMOD
8	is	be	VBZ	_	0	ROOT
9	defined	define	VBN	_	8	VC
10	as	as	IN	_	9	MNR
11	successful	successful	JJ	_	12	NMOD
12	pregnancies	pregnancy	NNS	_	10	PMOD
13	per	per	IN	_	12	NMOD
14	detected	detect	VBN	_	16	NMOD
15	vaginal	vaginal	JJ	_	16	NMOD
16	plug	plug	NN	_	13	PMOD
17	,	,	,	_	12	P
18	a	a	DT	_	19	NMOD
19	phenotype	phenotype	NN	_	12	APPO
20	associated	associate	VBN	_	19	NMOD
21	with	with	IN	_	20	ADV
22	early	early	JJ	_	24	NMOD
23	pregnancy	pregnancy	NN	_	24	NMOD
24	failure	failure	NN	_	21	PMOD
25	,	,	,	_	24	P
26	which	which	WDT	_	30	SBJ
27	in	in	IN	_	30	ADV
28	turn	turn	NN	_	27	PMOD
29	possibly	possibly	RB	_	30	ADV
30	could	could	MD	_	24	NMOD
31	have	have	VB	_	30	VC
32	an	an	DT	_	34	NMOD
33	inflammatory	inflammatory	JJ	_	34	NMOD
34	cause	cause	NN	_	31	OBJ
35	.	.	.	_	8	P

1	We	we	PRP	_	2	SBJ
2	can	can	MD	_	0	ROOT
3	not	not	RB	_	2	ADV
4	exclude	exclude	VB	_	2	VC
5	that	that	IN	_	4	OBJ
6	the	the	DT	_	8	NMOD
7	same	same	JJ	_	8	NMOD
8	gene	gene	NN	_	12	SBJ
9	(	(	-LRB-	_	8	P
10	s	s	AFX	_	8	NMOD
11	)	)	-RRB-	_	12	P
12	are	be	VBP	_	5	SUB
13	affecting	affect	VBG	_	12	VC
14	both	both	PDT	_	16	NMOD
15	these	these	DT	_	16	NMOD
16	traits	trait	NNS	_	13	OBJ
17	.	.	.	_	2	P

1	Conclusion	conclusion	NN	_	0	ROOT

1	Our	our	PRP$	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	show	show	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	multiparity	multiparity	NN	_	6	SBJ
6	does	do	VBZ	_	4	SUB
7	not	not	RB	_	6	ADV
8	negatively	negatively	RB	_	6	ADV
9	influence	influence	VB	_	6	VC
10	the	the	DT	_	11	NMOD
11	incidence	incidence	NN	_	9	OBJ
12	or	or	CC	_	11	COORD
13	severity	severity	NN	_	12	CONJ
14	of	of	IN	_	11	NMOD
15	CIA	cia	NN	_	14	PMOD
16	induced	induce	VBN	_	11	NMOD
17	later	later	RB	_	16	TMP
18	in	in	IN	_	17	AMOD
19	life	life	NN	_	18	PMOD
20	.	.	.	_	3	P

1	Furthermore	furthermore	RB	_	10	ADV
2	,	,	,	_	10	P
3	two	two	CD	_	5	NMOD
4	new	new	JJ	_	5	NMOD
5	loci	locus	NNS	_	10	SBJ
6	linked	link	VBN	_	5	NMOD
7	to	to	IN	_	6	ADV
8	CIA	cia	NN	_	9	NMOD
9	susceptibility	susceptibility	NN	_	7	PMOD
10	were	be	VBD	_	0	ROOT
11	detected	detect	VBN	_	10	VC
12	on	on	IN	_	11	LOC
13	chromosome	chromosome	NN	_	12	PMOD
14	11	0	CD	_	13	NMOD
15	(	(	-LRB-	_	16	P
16	Cia40	cia0	NN	_	13	PRN
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	12	COORD
19	on	on	IN	_	18	CONJ
20	chromosome	chromosome	NN	_	19	PMOD
21	1	0	CD	_	20	NMOD
22	.	.	.	_	10	P

1	We	we	PRP	_	2	SBJ
2	detected	detect	VBD	_	0	ROOT
3	on	on	IN	_	2	LOC
4	chromosome	chromosome	NN	_	3	PMOD
5	13	0	CD	_	4	NMOD
6	a	a	DT	_	7	NMOD
7	locus	locus	NN	_	2	OBJ
8	associated	associate	VBN	_	7	NMOD
9	with	with	IN	_	8	ADV
10	anti-CII	anti-cii	JJ	_	11	NMOD
11	titers	titer	NNS	_	9	PMOD
12	,	,	,	_	7	P
13	which	which	WDT	_	15	SBJ
14	probably	probably	RB	_	15	ADV
15	is	be	VBZ	_	7	NMOD
16	the	the	DT	_	17	NMOD
17	same	same	JJ	_	15	PRD
18	as	as	IN	_	17	NMOD
19	the	the	DT	_	22	NMOD
20	recently	recently	RB	_	21	AMOD
21	reported	report	VBN	_	22	NMOD
22	Cia28	cia0	NN	_	18	PMOD
23	[	[	-LRB-	_	24	P
24	19	0	CD	_	2	PRN
25	]	]	-RRB-	_	24	P
26	.	.	.	_	2	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	CIA	cia	NN	_	6	SBJ
2	=	=	SYM	_	6	P
3	collagen	collagen	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	induced	induce	VBN	_	6	NMOD
6	arthritis	arthritis	NN	_	42	DEP
7	;	;	:	_	42	P
8	CII	cii	NN	_	11	SBJ
9	=	=	SYM	_	11	P
10	collagen	collagen	NN	_	11	NMOD
11	type	type	NN	_	42	DEP
12	II	ii	CD	_	11	NMOD
13	;	;	:	_	42	P
14	LOD	lod	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	logarithm	logarithm	NN	_	42	DEP
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	19	NMOD
19	odds	odds	NNS	_	17	PMOD
20	;	;	:	_	42	P
21	MHC	mhc	NN	_	25	SBJ
22	=	=	SYM	_	25	P
23	major	major	JJ	_	25	NMOD
24	histocompatibility	histocompatibility	NN	_	25	NMOD
25	complex	complex	NN	_	42	DEP
26	;	;	:	_	42	P
27	PCR	pcr	NN	_	31	SBJ
28	=	=	SYM	_	31	P
29	polymerase	polymerase	NN	_	31	NMOD
30	chain	chain	NN	_	31	NMOD
31	reaction	reaction	NN	_	42	DEP
32	;	;	:	_	42	P
33	QTL	qtl	NN	_	37	SBJ
34	=	=	SYM	_	37	P
35	quantitative	quantitative	JJ	_	36	NMOD
36	trait	trait	NN	_	37	NMOD
37	locus	locus	NN	_	42	DEP
38	;	;	:	_	42	P
39	RA	ra	NN	_	42	SBJ
40	=	=	SYM	_	42	P
41	rheumatoid	rheumatoid	JJ	_	42	NMOD
42	arthritis	arthritis	NN	_	0	ROOT
43	.	.	.	_	42	P

1	Competing	compete	VBG	_	2	NMOD
2	interests	interest	NNS	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	declare	declare	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	they	they	PRP	_	6	SBJ
6	have	have	VBP	_	4	SUB
7	no	no	DT	_	9	NMOD
8	competing	compete	VBG	_	9	NMOD
9	interest	interest	NN	_	6	OBJ
10	.	.	.	_	3	P

1	Authors	author	NNS	_	3	NMOD
2	'	'	POS	_	1	NMOD
3	contributions	contribution	NNS	_	0	ROOT

1	ML	ml	NNP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	responsible	responsible	JJ	_	2	PRD
4	for	for	IN	_	3	AMOD
5	genotyping	genotyping	NN	_	9	NMOD
6	,	,	,	_	9	P
7	phenotyping	phenotyping	NN	_	9	NMOD
8	,	,	,	_	9	P
9	analyses	analysis	NNS	_	4	PMOD
10	and	and	CC	_	4	COORD
11	,	,	,	_	10	P
12	together	together	RB	_	16	PMOD
13	with	with	IN	_	12	AMOD
14	RM	rm	NNP	_	13	PMOD
15	,	,	,	_	16	P
16	for	for	IN	_	10	CONJ
17	interpretation	interpretation	NN	_	16	PMOD
18	and	and	CC	_	16	COORD
19	for	for	IN	_	18	CONJ
20	writing	write	VBG	_	19	PMOD
21	the	the	DT	_	22	NMOD
22	manuscript	manuscript	NN	_	20	OBJ
23	.	.	.	_	2	P

1	M	m	NNP	_	3	NMOD
2	-	-	HYPH	_	1	P
3	AS	a	NNP	_	6	SBJ
4	and	and	CC	_	3	COORD
5	SA	sa	NNP	_	4	CONJ
6	have	have	VBP	_	0	ROOT
7	contributed	contribute	VBN	_	6	VC
8	to	to	IN	_	7	ADV
9	collection	collection	NN	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	phenotype	phenotype	NN	_	12	NMOD
12	data	datum	NNS	_	10	PMOD
13	.	.	.	_	6	P

1	RM	rm	NN	_	8	SBJ
2	,	,	,	_	1	P
3	ÅA	åa	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	RH	rh	NNP	_	3	CONJ
6	and	and	CC	_	5	COORD
7	ML	ml	NNP	_	6	CONJ
8	designed	design	VBD	_	0	ROOT
9	the	the	DT	_	10	NMOD
10	study	study	NN	_	8	OBJ
11	.	.	.	_	8	P

1	All	all	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	read	read	VBD	_	0	ROOT
4	and	and	CC	_	3	COORD
5	approved	approve	VBD	_	4	CONJ
6	the	the	DT	_	8	NMOD
7	final	final	JJ	_	8	NMOD
8	manuscript	manuscript	NN	_	3	OBJ
9	.	.	.	_	3	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	This	this	DT	_	2	NMOD
2	study	study	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	ADV
6	Österlund	österlund	NNP	_	8	NMOD
7	's	's	POS	_	6	NMOD
8	fund	fund	NN	_	5	PMOD
9	,	,	,	_	8	P
10	Crafoord	crafoord	NNP	_	12	NMOD
11	's	's	POS	_	10	NMOD
12	fund	fund	NN	_	8	APPO
13	,	,	,	_	12	P
14	the	the	DT	_	19	NMOD
15	Gustav	gustav	NNP	_	16	NMOD
16	V	v	NNP	_	19	NMOD
17	80	0	CD	_	18	NMOD
18	Year	year	NNP	_	19	NMOD
19	Foundation	foundation	NNP	_	12	APPO
20	,	,	,	_	19	P
21	the	the	DT	_	24	NMOD
22	Royal	royal	NNP	_	24	NMOD
23	Physiographic	physiographic	NNP	_	24	NMOD
24	Society	society	NNP	_	19	APPO
25	in	in	IN	_	24	LOC
26	Lund	lund	NNP	_	25	PMOD
27	and	and	CC	_	5	COORD
28	by	by	IN	_	27	CONJ
29	Swegene	swegene	NNP	_	28	PMOD
30	.	.	.	_	3	P

1	Figures	figure	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Tables	table	NNS	_	2	CONJ

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	The	the	DT	_	3	NMOD
2	accumulated	accumulate	VBN	_	3	NMOD
3	incidence	incidence	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	arthritis	arthritis	NN	_	4	PMOD
6	in	in	IN	_	3	LOC
7	the	the	DT	_	9	NMOD
8	parental	parental	JJ	_	9	NMOD
9	strains	strain	NNS	_	6	PMOD
10	(	(	-LRB-	_	13	P
11	NFR	nfr	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	N	n	NN	_	9	PRN
14	and	and	CC	_	13	COORD
15	B10.Q	b0.q	NN	_	14	CONJ
16	)	)	-RRB-	_	13	P
17	of	of	IN	_	9	NMOD
18	female	female	JJ	_	19	NMOD
19	mice	mouse	NNS	_	17	PMOD
20	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Chromosomal	chromosomal	JJ	_	2	NMOD
2	locations	location	NNS	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	9	NMOD
5	quantitative	quantitative	JJ	_	6	NMOD
6	trait	trait	NN	_	7	NMOD
7	loci	locus	NNS	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	QTL	qtl	NN	_	3	PMOD
10	)	)	-RRB-	_	9	P
11	for	for	IN	_	9	NMOD
12	collagen	collagen	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	induced	induce	VBN	_	16	NMOD
15	arthritis	arthritis	NN	_	16	NMOD
16	incidence	incidence	NN	_	11	PMOD
17	on	on	IN	_	2	LOC
18	chromosomes	chromosome	NNS	_	19	NMOD
19	1	0	CD	_	17	PMOD
20	and	and	CC	_	19	COORD
21	11	0	CD	_	20	CONJ
22	.	.	.	_	2	P

1	QTL	qtl	NN	_	11	SBJ
2	for	for	IN	_	1	NMOD
3	collagen	collagen	NN	_	4	NMOD
4	type	type	NN	_	7	NMOD
5	II	ii	CD	_	4	NMOD
6	(	(	-LRB-	_	7	P
7	CII	cii	NN	_	10	NMOD
8	)	)	-RRB-	_	10	P
9	antibody	antibody	NN	_	10	NMOD
10	titers	titer	NNS	_	2	PMOD
11	are	be	VBP	_	0	ROOT
12	illustrated	illustrate	VBN	_	11	VC
13	on	on	IN	_	12	LOC
14	chromosome	chromosome	NN	_	13	PMOD
15	13	0	CD	_	14	NMOD
16	.	.	.	_	11	P

1	*	*	SYM	_	4	NMOD
2	Suggestive	suggestive	JJ	_	4	NMOD
3	level	level	NN	_	4	NMOD
4	threshold	threshold	NN	_	0	ROOT
5	(	(	-LRB-	_	8	P
6	P	p	NN	_	8	SBJ
7	=	=	SYM	_	8	P
8	0.63	0	CD	_	4	PRN
9	)	)	-RRB-	_	8	P
10	according	accord	VBG	_	4	NMOD
11	to	to	IN	_	10	PMOD
12	the	the	DT	_	14	NMOD
13	permutation	permutation	NN	_	14	NMOD
14	test	test	NN	_	11	PMOD
15	(	(	-LRB-	_	18	P
16	n	n	NN	_	18	SBJ
17	=	=	SYM	_	18	P
18	1,000	0	CD	_	14	PRN
19	)	)	-RRB-	_	18	P
20	.	.	.	_	4	P

1	**	**	SYM	_	4	NMOD
2	Significance	significance	NN	_	4	NMOD
3	level	level	NN	_	4	NMOD
4	threshold	threshold	NN	_	0	ROOT
5	(	(	-LRB-	_	8	P
6	P	p	NN	_	8	SBJ
7	=	=	SYM	_	8	P
8	0.05	0	CD	_	4	PRN
9	)	)	-RRB-	_	8	P
10	according	accord	VBG	_	4	NMOD
11	to	to	IN	_	10	PMOD
12	the	the	DT	_	14	NMOD
13	permutation	permutation	NN	_	14	NMOD
14	test	test	NN	_	11	PMOD
15	(	(	-LRB-	_	18	P
16	n	n	NN	_	18	SBJ
17	=	=	SYM	_	18	P
18	1,000	0	CD	_	14	PRN
19	)	)	-RRB-	_	18	P
20	.	.	.	_	4	P

1	Table	table	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Severity	severity	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	arthritis	arthritis	NN	_	2	PMOD
4	and	and	CC	_	1	COORD
5	anti-collagen	anti-collagen	JJ	_	6	NMOD
6	type	type	NN	_	9	NMOD
7	II	ii	CD	_	6	NMOD
8	(	(	-LRB-	_	9	P
9	anti-CII	anti-cii	JJ	_	11	NMOD
10	)	)	-RRB-	_	11	P
11	titers	titer	NNS	_	4	CONJ
12	in	in	IN	_	1	LOC
13	(	(	-LRB-	_	18	P
14	NFR	nfr	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	N	n	NN	_	18	NMOD
17	×	×	SYM	_	18	P
18	B10.Q	b0.q	NN	_	21	NMOD
19	)	)	-RRB-	_	18	P
20	×	×	SYM	_	21	P
21	B10.Q	b0.q	NN	_	23	NMOD
22	female	female	JJ	_	23	NMOD
23	mice	mouse	NNS	_	12	PMOD
24	and	and	CC	_	23	COORD
25	parental	parental	JJ	_	26	NMOD
26	strains	strain	NNS	_	24	CONJ

1	a	a	LS	_	3	NMOD
2	Median	median	NN	_	3	NMOD
3	value	value	NN	_	0	ROOT
4	on	on	IN	_	3	TMP
5	the	the	DT	_	6	NMOD
6	days	day	NNS	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	onset	onset	NN	_	7	PMOD
9	when	when	WRB	_	10	TMP
10	calculated	calculate	VBN	_	6	NMOD
11	in	in	IN	_	10	LOC
12	all	all	DT	_	14	NMOD
13	arthritic	arthritic	JJ	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	in	in	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	group	group	NN	_	15	PMOD
18	on	on	IN	_	10	TMP
19	day	day	NN	_	18	PMOD
20	100	0	CD	_	19	NMOD
21	(	(	-LRB-	_	25	P
22	maximum	maximum	JJ	_	24	NMOD
23	–	–	HYPH	_	22	P
24	minimum	minimum	JJ	_	25	NMOD
25	values	value	NNS	_	10	PRN
26	in	in	IN	_	25	NMOD
27	the	the	DT	_	28	NMOD
28	series	series	NN	_	26	PMOD
29	)	)	-RRB-	_	25	P
30	.	.	.	_	3	P

1	b	b	LS	_	5	NMOD
2	Mean	mean	NN	_	5	NMOD
3	±	±	SYM	_	5	P
4	standard	standard	JJ	_	5	NMOD
5	error	error	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	maximum	maximum	JJ	_	9	NMOD
9	score	score	NN	_	6	PMOD
10	from	from	IN	_	9	NMOD
11	all	all	DT	_	13	NMOD
12	arthritic	arthritic	JJ	_	13	NMOD
13	mice	mouse	NNS	_	10	PMOD
14	in	in	IN	_	13	NMOD
15	the	the	DT	_	17	NMOD
16	respective	respective	JJ	_	17	NMOD
17	group	group	NN	_	14	PMOD
18	.	.	.	_	5	P

1	c	c	LS	_	3	AMOD
2	Significantly	significantly	RB	_	3	AMOD
3	higher	high	JJR	_	0	ROOT
4	than	than	IN	_	3	AMOD
5	in	in	IN	_	4	LOC
6	B10.Q	b0.q	NN	_	7	NMOD
7	mice	mouse	NNS	_	5	PMOD
8	(	(	-LRB-	_	11	P
9	P	p	NN	_	11	SBJ
10	=	=	SYM	_	11	P
11	0.02	0	CD	_	7	PRN
12	in	in	IN	_	11	NMOD
13	Student	student	NNP	_	17	NMOD
14	's	's	POS	_	13	NMOD
15	unpaired	unpaired	JJ	_	17	NMOD
16	t	t	NN	_	17	NMOD
17	test	test	NN	_	12	PMOD
18	)	)	-RRB-	_	11	P
19	.	.	.	_	3	P

1	Table	table	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Incidence	incidence	NN	_	0	ROOT
2	,	,	,	_	1	P
3	onset	onset	NN	_	1	CONJ
4	and	and	CC	_	3	COORD
5	maximum	maximum	JJ	_	6	NMOD
6	score	score	NN	_	4	CONJ
7	in	in	IN	_	1	LOC
8	(	(	-LRB-	_	13	P
9	NFR	nfr	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	N	n	NN	_	13	NMOD
12	×	×	SYM	_	13	P
13	B10.Q	b0.q	NN	_	16	NMOD
14	)	)	-RRB-	_	13	P
15	×	×	SYM	_	16	P
16	B10.Q	b0.q	NN	_	18	NMOD
17	female	female	JJ	_	18	NMOD
18	mice	mouse	NNS	_	7	PMOD

1	a	a	LS	_	3	NMOD
2	Median	median	NN	_	3	NMOD
3	value	value	NN	_	0	ROOT
4	on	on	IN	_	3	TMP
5	the	the	DT	_	6	NMOD
6	days	day	NNS	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	onset	onset	NN	_	7	PMOD
9	when	when	WRB	_	10	TMP
10	calculated	calculate	VBN	_	3	TMP
11	in	in	IN	_	10	LOC
12	all	all	DT	_	14	NMOD
13	arthritic	arthritic	JJ	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	in	in	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	group	group	NN	_	15	PMOD
18	(	(	-LRB-	_	22	P
19	maximum	maximum	JJ	_	21	AMOD
20	–	–	HYPH	_	19	P
21	minimum	minimum	JJ	_	22	NMOD
22	values	value	NNS	_	10	PRN
23	in	in	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	series	series	NN	_	23	PMOD
26	)	)	-RRB-	_	22	P
27	.	.	.	_	3	P

1	b	b	LS	_	6	NMOD
2	Mean	mean	NN	_	6	NMOD
3	(	(	-LRB-	_	6	P
4	±	±	SYM	_	6	P
5	standard	standard	JJ	_	6	NMOD
6	error	error	NN	_	0	ROOT
7	)	)	-RRB-	_	6	P
8	of	of	IN	_	6	NMOD
9	the	the	DT	_	11	NMOD
10	maximum	maximum	JJ	_	11	NMOD
11	score	score	NN	_	8	PMOD
12	from	from	IN	_	11	NMOD
13	all	all	DT	_	15	NMOD
14	arthritic	arthritic	JJ	_	15	NMOD
15	mice	mouse	NNS	_	12	PMOD
16	in	in	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	respective	respective	JJ	_	19	NMOD
19	group	group	NN	_	16	PMOD
20	on	on	IN	_	11	TMP
21	day	day	NN	_	20	PMOD
22	100	0	CD	_	21	NMOD
23	.	.	.	_	6	P

1	Table	table	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Distribution	distribution	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	genotypes	genotype	NNS	_	2	PMOD
4	between	between	IN	_	3	NMOD
5	affected	affected	JJ	_	9	NMOD
6	and	and	CC	_	5	COORD
7	unaffected	unaffected	JJ	_	6	CONJ
8	N2	n0	NN	_	9	NMOD
9	mice	mouse	NNS	_	4	PMOD
10	at	at	IN	_	1	LOC
11	different	different	JJ	_	12	NMOD
12	loci	locus	NNS	_	10	PMOD
13	linked	link	VBN	_	12	NMOD
14	to	to	IN	_	13	ADV
15	clinical	clinical	JJ	_	16	NMOD
16	phenotypes	phenotype	NNS	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	collagen	collagen	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	induced	induce	VBN	_	21	NMOD
21	arthritis	arthritis	NN	_	17	PMOD

1	*	*	SYM	_	3	NMOD
2	Suggestive	suggestive	JJ	_	3	NMOD
3	significance	significance	NN	_	0	ROOT
4	,	,	,	_	3	P
5	**	**	SYM	_	6	NMOD
6	significant	significant	JJ	_	3	APPO
7	.	.	.	_	3	P

